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Dynamic Contrast-Enhanced Imaging (DCE) is one of the main tools for in vivo measurement of vascular 
properties of pathologies such as brain tumors. In DCE imaging, one of the key components for 
estimation of vascular perfusion and permeability parameters using Pharmacokinetic models is the 
Arterial Input Function (AIF).  To measure these parameters more accurately, there have been many 
approaches for estimating the AIF profile at the capillary level; however, a practical and realistic estimate 
is still missing.  
As a solution to this problem, we have developed a model of the brain vascular system, based on laws of 
fluid dynamics and vascular morphology, to address dispersion and delay of the contrast agent (CA) 
concentration profile at different levels of the brain vascular tree. Using this model, we introduced a 
transfer function that can describe changes of the AIF profile along a vascular pathway, from a major 
artery to the capillary bed. Our simulations and also testing this model on DCE Computed Tomography 
(DCE-CT) and Magnetic Resonance (DCE-MR) Imaging data of the human brain, all showed that our 
model can give a realistic estimation of the CA concentration profile, at all levels of the vascular tree in 
the brain.  
In the next step, to apply this model to pathologies such as brain tumors, in which leakage of the contrast 
agent to the extravascular-extracellular space (EES) can happen, we extended our model to address 
vascular leakage as well. Using this extended vascular (EV) model, we are able to decompose the tissue 
response signal in DCE images to its intravascular and EES components. This feature has provided us 
with an excellent tool that can lead to relatively unbiased measurements of perfusion and permeability 
parameters, especially in areas with vascular leakage. We tested this on DCE-CT and DCE-MR images 
and compared the performance of our model to conventional methods. Also, using a simulation study, we 
measured the levels of overestimation and underestimation of the permeability parameters using 
conventional processing methods and demonstrated the superior performance of the EV model for more 
accurate estimation of these parameters. 
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Overall, the results show that the EV model proposed in this study can provide a platform for better 
understanding of the role of the AIF in DCE studies as well as identification and estimation of AIF for 
more accurate measurement of perfusion and permeability parameters.  This model can have a significant 










In this chapter, the importance of the Arterial Input Function (AIF) and its significance for 
measuring the permeability and perfusion parameters in Dynamic Contrast Enhanced (DCE) 
imaging is reviewed. The problems associated with the conventional use of AIF in these studies 
will be introduced which is the motivation behind this dissertation. 
Estimating the Arterial Input Function (AIF) of a Contrast Agent (CA), the time-concentration 
curve in plasma, especially at the tissue level, has long presented a problem in Dynamic Contrast 
Enhanced Magnetic Resonance (DCE-MR) and Dynamic Susceptibility Contrast Magnetic 
Resonance (DSC-MR) imaging Arterial Spin Labeling (ASL) and Dynamic Contrast Enhanced 
Computed Tomography (DCE-CT) studies. All these methods are based on changing the contrast 
of the images in the vascular areas by means of a tracer. This tracer can be endogenous (ASL) or 
exogenous (DSC-MR, DCE-MR and DCE-CT) [1].In the MRI field, DSC is the method of 
choice for perfusion studies in which  Mean Transit Time (MTT) , Cerebral Blood Flow (CBF) 
and Cerebral Blood Volume (CBV) are estimated [2] and is based on changes of the T2
*
 signal in 
the dynamic images[1]. In DCE-MRI studies, dynamic series of T1-weighted images are 
acquired and is mainly used for estimation of vascular permeability parameters such as vascular 
transfer rate constant (K
trans
), vascular plasma volume (vp), and extracellular-extravascular space 
(EES) volume (ve) [3, 4]. 
One of the main components in the methods for estimating the parameters mentioned above is 
the AIF [5] Inaccurate estimation of the AIF for use in permeability and perfusion analyses could 
substantially add bias to the estimated hemodynamic and permeability maps. This is one of the 
main reasons for finding the Arterial Input Function (AIF) at the tissue level (which we will refer 
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to as “Tissue Input Function” or TIF).  One approach towards this goal is modeling the vascular 
system in the brain and using that to find the dynamics of blood flow at the capillary (tissue) 
level which is the main focus of this dissertation 
Some of the earliest studies to understand and quantitate the morphology of the vascular system 
and dynamics of blood flow was done by Cecil Murray [6, 7] in the early 20th century where the 
relationship between the rate of blood flow and the volume of the vessel and also his well-known 
arterial branching rule [7, 8] were interpreted based on the principle of minimum work. Another 
direction for measuring the blood flow is the “Indicator-Dilution Method” which is basically 
what DCE is based on. The first reported work in this field was done between 1824 and 1826 by 
Herring where he was trying to measure “velocity” in the blood circulation system by injecting 
ferrocyanide in the jugular vein of 14 horses and sampling it at other parts of their vascular 
system [9] In the late 19th century and early 20th century other scientists carried out experiments 
in this field. However the work done by Kenneth Zierler during the 1950‟s and 1960‟s set up the 
building blocks and equations of Indicator Dilution Theory (IDT) that we are using to this day 
[10-14].   
In the past couple of decades, many researchers have attempted to model vasculature for 
applications in DSC and DCE studies. Depending on the applications, there have been different 
approaches to this problem, each having their advantages and shortcomings. In one study 
Calamante et al. proposed using Independent Component Analysis (ICA) in perfusion studies as 
a tool to define a local AIF for obtaining more accurate quantification of CBF in DSC-MRI 
studies [15]. Using the local AIF resulted in obtaining higher CBF and shorter MTT in areas with 
distorted AIFs which suggests minimized delay/dispersion. The method for finding the local AIF 
was based on a semi-manual approach and user input was required for choosing the components 
and also there was no method for validating the local AIF; another shortcoming of this method 
was the assumption that the AIF is similar between neighboring voxels. Mouridsen et al. defined 
a physiological estimation of microvasculature which was used for estimation of cerebral 
perfusion with Bayesian methods [16]. The model that they designed for microvasculature is 
basically a set of parallel delay lines each representing an arteriole and a capillary and each 
having a different transit time. The assumption for the AIF in this work was having a gamma-
variate Probability Density Function (PDF) which is a simplified form of the actual AIF in 
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vasculature; this function or the exponential decay function for the local AIF are assumptions 
that have been used in other studies as well [17, 18]. 
Cebral et al. used noninvasive methods to develop detailed assessment of blood flow patterns 
from direct in vivo measurements of vessel anatomy and flow rates using finite element methods 
[19].  They used MR angiograms for imaging the Carotid artery in patients with stenosis, and 
blood flow was modeled in this artery for each patient. The goal of this work was 
characterization of blood flow patterns in healthy and diseased carotid arteries. The main 
attraction of this work is the detailed modeling of blood flow and turbulence at the bifurcation 
point in a major artery; however, the whole blood circulation in the brain and in smaller arteries 
and tissue was not modeled.  
In a recent work, Li et al. created a method for tracking the AIF in DCE-MRI images of the 
breast [20]. However, this method was only focused on finding the voxels in the images that 
showed characteristics of being representative of the AIF and the goal of Li‟s work was not for 
finding a TIF. 
Another approach was modeling the blood circulatory system of the whole body and finding the 
flow at different locations in the vascular system. In this category, Sherwin et al. built a one 
dimensional network based on space-time variables and linear and non-linear modeling [21]. 
They first derived the governing equations by considering the conservation of mass and 
momentum for a single one-dimensional vessel and they applied these equations to a network 
and adding the effects of bifurcation and dispersion. They tested this model on a network 
containing 55 arteries. Another modeling approach is Three-Dimensional One-Dimensional 
coupled models. The concept of a coupled model is based on having a Three-Dimensional 
arterial district embedded in a One-Dimensional representation of the arterial system [22] The 
use of Three-Dimensional One-Dimensional coupled models allows performing quantitative and 
qualitative studies about local and global hemodynamic quantities but none of the models above 
have addressed the model of the flow at the capillary (tissue) level and are useful mainly for 
modeling flow in arteries in healthy and abnormal conditions such as aneurisms. In another 
study,  Bagher-Ebadian et al.  suggested a model, based on the blood-circulatory system, for the 
construction of an algorithm for estimating the CA time-concentration curve in arterial plasma 
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after an intravenous bolus injection [23, 24]. A set of time courses of radiolabeled Gd-DTPA CA 
concentrations in arterial plasma (time–activity curve) after an intravenous bolus injection were 
measured by counting β emissions in a well counter for 13 Wistar rats. The measured AIF 
profiles were averaged and calibrated to blood relaxivity to construct a reference curve (ΔR1) for 
constructing a standard radiological AIF (SRAIF). Next, the SRAIF curve was used to estimate 
the blood-circulatory model parameters to construct a standard model based AIF in a high 
temporal resolution which can be adapted to any MR DSC and DCE studies [25]. This model 
based AIF (SRAIF) can be used in the animal model.  The models suggested above mainly focus 
on estimating the AIF signal in major arteries. These models work reasonably when only a global 
AIF is used in the perfusion and permeability analyses. 
As we mentioned, one application of AIF estimation is in ASL. One major difference between 
ASL studies and DCE-MR, DSC-MR and DCE-CT studies (which are considered CA based 
studies) is the profile of the bolus at the location of major artery entering the brain. In ASL, a 
square shaped bolus (which is considered as the ideal AIF in ASL studies [26]) is formed inside 
the major artery by radiofrequency excitation of the water protons in the arterial blood, which is 
then imaged after a delay, to allow the bolus of labeled blood reach the tissue of interest. Any 
modeling for finding the dispersion in the flow pathway in ASL can use the box-car bolus as the 
input. On the other hand, in the CA based studies, the CA bolus is injected intravenously and 
after arriving at the major artery in the brain, it totally gets deformed and dispersed. This point 
makes the models used in ASL studies (that assume the square shape for the bolus), not directly 
useable for the CA based studies. There has been considerable number of studies for modeling 
changes in the AIF for ASL applications. Some have used Gaussian kernels [27]  or variations of 
it [28] for modeling dispersion of the AIF which provide plausible smoothening of the AIF box-
car shape along the arterial pathway. Hernandez et al. previously presented a one dimensional 
model for ASL applications that takes into account the effects of transit times by modeling  
displacement and decay of the inversion tag between the tagging and imaging locations [29]. In 
this study, the numerical ASL model was based on a series of arterial compartments. Passing of 
the inversion tag through each compartment was characterized by the transport equation, a decay 
term and the exchange of the tag with the tissue. In the transport equation, the mean arterial 
velocity function was incorporated which reflected the changes of the transit time along the path. 
Also, to take into account the dispersion effects of the laminar flow, the AIF was smoothened 
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using a Gaussian kernel.  In another study, Kazan et al. modeled the effects of dispersion in 
Arterial Spin Labeling (ASL) [30]. In their model, the mass transport equation has been used to 
model the transport of the ASL signal from the tagging band to the imaging band. They have 
accounted for flow dispersion through the use of a more physically realistic representation of the 
transit of the bolus compared to the existing ASL models and they have managed to get more 
accurate results using the dispersion model; in neither of the studies above has the effects of 
multiple pathways of flow through the vasculature been considered for modeling the overall 
dispersion. In another study dispersion of the AIF was modeled based on laminar (parabolic) and 
pulsatile flow of blood in major arteries [31]. Since this model was designed to address the signal 
changes for  applications in ASL, it had incorporated parameters and components such as the tag 
delivery function and decay function which are relevant to ASL studies. The result of this work 
is a four phase equation describing the effects of labeling the cross section of a tube (in the form 
of a square label profile), after moving a certain distance from it to the imaging location.  The 
advantage of this model was considering the effects of blood flow, including laminar and 
pulsatile flow in the model; however, this was designed only for ASL applications and also it 
was considering only a single tube with no branching which is the real case in all vascular 
structures.  Later Chapelle et al. used a variation of this model with adding a gamma-variate 
kernel to address dispersion in ASL [26]. Using Dynamic Angiographic measurements in major 
arteries, this study showed that the gamma-variate model can explain dispersion of the ASL 
bolus in these arteries.  
One issue with the suggested models in DCE studies is clinically validating them and the 
estimated parameters in the human brain [32]. Although there have been attempts to address this 
issue by developing phantoms to simulate perfusion, most of these systems fail to establish and 
accurately replicate physiologically relevant capillary permeability and exchange performance. 
One approach to solving this problem has been using concepts of physics and transport 
phenomena for better understanding of contrast agent kinetics. In one approach, Peladeau-Pigeon 
and Coolens [32] used the results of a Computational Fluid Dynamics (CFD) simulation and 
DCE-CT data obtained from a flow phantom to test Tofts [33] enhanced model and Fick‟s 
principle [34] The phantom used in this study contained a single tube. As will be discussed later 
in this dissertation, we have used a similar approach for simulating such physical model; 
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however, effects of dispersion due to vascular branching and flow have also been incorporated in 
our model. 
The methods discussed above show different models for the AIF but these models either 
represent the input function only at the level of the major arteries (such as the carotid artery) or if 
they have an estimation of the input function at a lower level, the model does not represent all 
the major parameters that affect the AIF at the capillary level. Here we introduce a method that 
not only presents an analytical approach for modeling the dispersion in major arteries at different 
levels of branching, but is also able to present a model of the TIF using Laws of fluid dynamics 
and morphological properties of the vessels. 
In Chapter II first a brief overview of vascular neuroanatomy and hemodynamics will be given. 
Next we will introduce the parametric equation of the transfer function of a single vessel that we 
have calculated and based on that we will present our basic model of the vascular structure of the 
brain. In Chapter III, initially a method will be introduced based on fitting and model averaging, 
to be used for finding the branching level and vascular characteristics of the vessel that the CA 
profile is sampled from. Next the results of testing this method on simulated data and DCE-CT 
images will be presented after that the software platform for processing the DCE images using 
this method is introduced. Chapter IV starts with reviewing the concepts of Indicator-Dilution 
Theory and the Pharmacokinetic Model. After that, the methods that we have developed for 
estimating T1 maps and also the ∆R1 signal will be discussed. Next, the models of vascular 
leakage will be introduced and then we will describe our method for finding permeability 
parameters using fitting and model selection. In Chapter V we will introduce the extended 
vascular model which combines the basic vascular model with the concept of vascular leakage. 
In this chapter, the application of this method for decomposing the tissue response signal into 
intravascular and extravascular components is explained and the results of testing the model on 
DCE-CT and DCE-MRI images are presented. The main focus of Chapter VI is on comparing 
the effects of using different AIFs on the estimated values of the permeability parameters. The 
AIFs discussed in this chapter are the Manually Selected AIF (MSAIF), Standard Radiological 
AIF (SRAIF), and the TIF found using our Extended Vascular Model. Also results of using ∆R1 
vs. DCE-T1 signal intensity for calculation of permeability parameters are compared. At the end 
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of this chapter, the advantage of the Extended Vascular Model for perfusion studies is discussed. 









VASCULAR MODELING OF THE BRAIN 
This goal of this research is finding an estimate of dispersion of the contrast agent profile in the 
brain tissue and different layers of the vascular structure. For this reason, knowledge of the 
vascular anatomy of the brain and also dynamics of blood flow in these vessels is necessary. In 
this chapter, after addressing these, a model will be introduced that can analytically model 
dispersion of the contrast agent profile in the brain vascular structure. 
2.1 Vascular Anatomy of the Brain 
In this research, our goal is finding dispersion of the contrast agent profile at the all vascular 
levels in the brain, from the main arteries entering the brain to the veins that collect the blood 
from the venules and capillaries and exit the brain. One critical point is the fact that more than 
one artery enters the brain and it is critical to study the anatomy of these vessels and for finding 
the relationship of the contrast agent profile at the entry point of these vessels to the brain and 
also how these vessels branch into the brain. 
2.1.1 Anatomy of Arteries between the Heart and the Brain 
Figure 2.1 shows the fontal view of the arteries connecting Aorta to the brain [35]. As seen here 
the right common carotid artery begins at the bifurcation of the brachiocephalic trunk and the 
right vertebral artery originates from the right subclavian artery which is also a branch of the 
brachiocephalic trunk. In contrast, the left common carotid artery branches out directly from the 
aortic arch and the left vertebral artery arises from the left subclavian artery. Both (left and right) 
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common carotid arteries bifurcate into the internal and external carotid arteries. The external 
branches of the carotid arteries basically feed the organs outside the brain, such as the facial and 
lingual structures and don‟t enter the brain.  The Left and Right Vertebral Arteries join together 
to form the Basilar Artery. This Artery along with the Left and Right Internal Carotid Arteries 
are the main arteries that flow into the circle of Willis (Figure 2.2) to supply the brain tissue. 
 
Figure 2.1. Frontal view of the main arteries entering the brain. Here, the vertebral arteries,  carotid arteries and 
intracranial vessels are seen. The main arteries that enter the brain are the left and right Internal Carotid Arteries and 
the Basilar Artery. (Figure courtesy of Renan Uflacker. Atlas of Vascular Anatomy an Angiographic Approach: Second 





Figure 2.2. Schematic diagram of the circle of Willis and the major efferent and afferent arteries connected to it. The Left 
and Right Internal Carotid Arteries and the Basilar Artery are the main sources of blood flow into the circle of Willis and 
the blood is directed to the different cerebral regions through the Left and Right MCA, PCA and ACA. Considering the 
short vascular distance between the different efferent arteries and also the relatively low temporal resolution of the 
dynamic images, it is assumed that the profile of the CA entering each of these arteries is similar in these vessels. 
2.1.2 Anatomy of Vessels Inside the Brain 
As seen in Figure 2.2, after entering the circle of Willis through the Basilar and Internal Carotid 
Arteries, the blood flow gets divided into six main branches. These are the Left and Right 
Anterior Cerebral Arteries, Middle Cerebral Arteries and Posterior Cerebral Arteries [36]. Each 
of these arteries supplies a different region in the brain.  
The goal of our study is to model the vascular trees in the brain and based on that, measure the 
dispersion of the contrast agent profile in the brain. Therefore, it is crucial to have a good 
estimate of the number of bifurcation levels of the vasculature after the circle of Willis. To this 
date the most extensive report for quantification of the global and local anatomical features of 
arterial vasculature can be seen in a study by Wright et al. [36]. In this study, using MR 
Angiograms from a human population of 61 subjects, the size, symmetry, branching 
characteristics, bifurcation angles, and path meandering of brain arteries have been measured. 
11 
 
According to this study, the maximum number of bifurcations in the three vascular trees are 6.15 
± 1.53 (ACA), 8.80 ± 1.40 (MCA), and 5.93 ± 1.66 (PCA). In our research, six levels was the 
maximum number of bifurcations that was considered. 
2.2 Hemodynamics  
Hemodynamics is the study of blood flow or blood circulation. It explains the physical laws that 
govern the flow of blood in the blood vessels. This is a vast field and addresses many different 
aspects of the vascular system. Here we only focus on a few concepts that we will be dealing 
with in our model. 
Blood flow in the vessels is of pulsatile nature; however, as the blood flows from the major 
arteries into smaller arteries and arterioles the pulsatile effects of the blood get reduced and get 
closer to continuous flow. The flow of blood in the vascular system can be divided into three 
types: 
- Turbulent flow 
- Laminar flow 
- Plug flow 
The first two types of flow are seen in larger vessels while plug flow occurs in capillaries in 
which the white and red blood cells squeeze through the vessels as a solid mass. Figure 2.3 
shows the pattern of the movement of fluid particles in a cylindrical tube for Turbulent and 
Laminar flow. In laminar flow, all the elements of the fluid move in streamlines parallel to the 
axis of the tube; but in turbulent flow, the elements of fluid move axial, radial and 
circumferential directions irregularly.  
The occurrence of turbulent or laminar flow mainly depends on the Reynolds number (Re). Re is 
a dimensionless number that gives an estimate of the ratio of inertial forces to viscous forces. For 
a cylindrical tube [34]:  
(2.1)     
                      
                     
  
     
     
  







Figure 2.3. Movement of particles in Laminar and Turbulent flow in a vessel. In laminar flow, all the elements of the fluid 
move in streamlines parallel to the axis of the tube; but in turbulent flow, the elements of fluid move axial, radial and 
circumferential directions irregularly. 
Here,   is the density and   is the viscosity of blood.  L and v are characteristics of length and 
velocity respectively. As seen here, the velocity of the fluid and the diameter of the vessel can 
increase the Reynolds number.  Generally speaking, higher velocity and larger opening for the 
tube would lead to a higher Reynolds number. One of the main parameters that cause flow to 
switch between turbulent and laminar forms is the value of Re. For cylindrical tubes, flow is 
always laminar for Re < 2100 but if the inner walls of the cylinder are smooth and there are no 
vibrations, laminar flow can continue to happen up to Re values around 10,000. In section 2.3.1 
we will talk more on the measured and estimated values for the Reynolds number of blood in 
major arteries and also based on the equation of the velocity of fluids in laminar flow, will model 
the flow of blood in vessels. 
One of the parameters that we deal with when calculating the permeability parameters of vessels 
using the Pharmacokinetic model is the Hematocrit (Hct). Hematocrit is defined as the volume 
percentage of erythrocytes in blood [37] and is normally about 45% for men and 40% for women 
[38]. Another important concept that should be noted here is the Fahraeus-Lindquist Effect [39]. 
Based on this effect, when blood moves from larger to smaller vessels its viscosity decreases. 
This effect is mainly seen in vessels with a diameter below 0.3mm where the viscosity strongly 
decreases with the reduced diameter of the vessels. The result of this effect is the reduced 
resistance to blood flow in these vessels. Based on this effect, the relative hematocrit ratio of the 
blood will change as it moves from larger vessels to tissue. For more accurate solutions for the 
pharmacokinetic model, this should effect should be considered [40].  
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2.3 Modeling Blood Flow in the Vessels  
In this section, the steps and building blocks of our vascular model is described. First, we 
describe the dispersion of the contrast agent profile in a single vessel due to the laminar flow of 
blood in large vessels and using that, we find a parametric expression for the transfer function of 
single vessel. In the next step, we model the morphological structure of vessels and finally, by 
combining these results, we model the overall transfer function of vessels in the brain. 
2.3.1 Transfer Function of a Single Vessel 
As mentioned in section 2.2, the flow of blood in vessels in the body can fall in any of the three 
categories of Turbulent flow, Laminar flow or Plug flow. One of the factors that determine the 
type of flow in vessels is the Reynolds number (Re). The value of Reynolds number in different 
vessels changes based on the diameter of the vessel and the velocity of blood. The vessel that has 
the highest value of Reynolds number is the Ascending Aorta which has a peak value of 4500 
(and a mean of 750). Typically, turbulent flow starts at Reynolds numbers higher than 4000 [34]. 
The focus in this study is on vessels in the brain. The largest vessel entering the brain is the 
Internal Carotid Artery (ICA). The average Re for the ICA has been calculated to be 266 and 911 
for the mean and peak flow rates respectively [41]. Also Laser Doppler measurements of 3D 
flow models of the ICA have given a value of 700 for the Reynolds number in these vessels [42]. 
Considering these reports, the possibility of having Turbulent flow in any of the vessels in the 
brain is excluded since they are less than 4000. Also, it is known that that in micro vessels, blood 
flows in the form of plug flow [34]. Based on this, for finding the dispersion, the focus will be on 
the arteries, arterioles, veins and venules in the brain where flow is laminar and dispersion due to 





Figure 2.4. (a) Introduction of a contrast agent in the form of a step function to a vessel with laminar flow. (b) The 
parabolic form of the contrast agent after flowing the distance of D0 in the vessel at time t while entering the volume 
enclosed by planes at D0 and D0+ΔD (c) The next step where the tip of the parabola exits the enclosed volume. 
Figure 2.4 shows the effect of laminar flow on the shape of the profile of the contrast agent along 
the vessel after it is presented to the entrance of the vessels as a bolus. In laminar flow,  the 
velocity of the fluid in a tube is dependent on the radial distance to the center of the tube and can 
be characterized as [34]: 




where    is the velocity of blood along the central axis of the vessel (maximum velocity) with a 
radius of  .   is the blood velocity at the radial distance   from this axis.    is calculated by: 
(2.3)          
    
   
 
  and R are the length and radius (m) of the tube,     is the pressure drop across the tube (or the 
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pressure difference between the ends of the tube) (Pa) and   is the blood viscosity (Pa·s). In this 
study, considering the time resolution of DCE imaging,  the effects of pulsatile flow of blood in 
the vessels  are ignored and it is assumed that flow has reached a steady state; this indicates that 
the blood velocity in every vessel has a value that is dependent on the overall structure of the 
vascular system and it will be assumed that the effect of the whole system on flow has already 
taken place and has resulted in the maximum velocity being    in this particular vessel and from 
this point on,    will represent the flow in the vessels. 
 As shown in Figure 2.4-a, contrast agent is introduced to the entrance of the vessel in the form 
of a step function. The goal is to find an equation that shows the concentration of the Contrast 
Agent (CA) in the volume enclosed by the two planes at    and     , as a function of time. 
We will use this equation to find a transfer function for this vessel.  
The equation of the surface of the parabola is written as: 
(2.4)        
  
  
   
As seen in Figure 2.4-b, initially the CA enters this space between the two planes, but does not 
pass through the second plane. For calculating the transfer function of the vessel, we assume the 
condition where the tip of the parabola has crossed the second plane and    is assumed to be 
small. Considering these conditions, at the intersection of the parabola and the    plane, the 
following equation holds:  




   
Where    the radius of the circular is cross section of the parabola and the    plane and   is the 
time taken for the CA to reach the    plane at the    radius.  
The shortest time for the bolus to reach the     plane is defined as   : 




By rearranging Equation 2.5 and using Equation 2.6, we have: 
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(2.7)   




Using   , the volume of the parabola (CA) enclosed between the two planes is calculated as: 
(2.8)        
    
And by dividing this volume by the total cylinder volume enclosed between the two planes, the 
CA concentration in this segment of the vessel can be found: 
(2.9)          
   
    
 
   
   
     




This equation shows the CA concentration with respect to time for a step function as the input. If 
the time derivative of the equation is calculated, the response to the delta function or in other 
words, the transfer function can be calculated. By calculating the derivative with respect to time, 
the impulse response or transfer function of a single vessel can be found: 




Considering the fact that the no contrast agent passes through the    plane before time   , the 
transfer function of a single vessel is as follows: 
(2.11)       {
      
  
  
    
 
   is the length of the vessel and    the maximum velocity of blood in that vessel so    is the 
shortest time that the contrast agent takes to reach the end of the vessel. Figure 2.5 shows the plot 
of the transfer function of a single vessel. Using this transfer function and by knowing the flow 
rate in a cascade of the vessels, the transfer function at each node in the network can be found by 




Figure 2.5. Plot of the transfer function of a single vessel. t0 represents the time the tip of the CA parabola reaches the end 
of the vessel. 
2.3.2 Three Dimensional Model of the Brain Vascular Structure 
After calculating the transfer function of a single vessel, the next step is finding the transfer 
function (and distortion) of a cascade of branching vessels such that the morphological model of 
the brain vasculature is implemented and the flow and distortion at each level is calculated. For 
this purpose, a model of the vessels was designed for finding the flow and dispersion from an 
artery to arterioles down to capillaries and from those to the venules and veins. Figure 2.6 shows 
the Three-Dimension representation of this model. In this model, the artery at the first level is 
assigned a diameter and flow value close to those of the three main arteries branching from the 
circle of Willis. At the end of this vessel, bifurcation happens and two daughter vessels are 
created. The radii of these daughter vessels are found based of Murray‟s branching law of vessels 
[6, 8]. Based on this law, the radii of the three vessels are related through the following equation: 
(2.12)   
      
      
  
Where    is the radius of the parent vessel and     and     are the radii of the two daughter 
vessels.  In this model, first     is selected randomly as a fraction of    and next,     is calculated 
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based on Murray‟s law, and the values of    and    . The length of the daughter vessels are also 
selected randomly within a certain range as a fraction of the length of the parent vessel. Using 
the same procedure for creating the daughter vessels, based on a recursive rule, the branches can 
be created to as many levels as desired. To follow the branching in the brain down to the 
capillaries, this is repeated up to 6 levels. The vessels at the 6th level represent the last level of 
arterioles. The reason for selecting 6 levels will be discussed in section 2.2.2. 
After implementing the morphological model of the vascular structure, the next step is 
calculating the flow rate in the branches. Volumetric flow rate is defined as [34]: 
(2.13)    〈 〉   
Here, 〈 〉 is the mean velocity of fluid and   is the cross sectional area of the vessel. In laminar 
flow [34], 
(2.14) 〈 〉   
 
 
   
In branching vessels, the volumetric flow rate of a non-compressible fluid can be calculated as 
follows: 
(2.15)           
This means that the volumetric flow rate of fluid in the parent branch (Qp) equals the volumetric 
flow rate in the daughter branches (Q1 and Q2). Accurate calculation of the ratio of the flow rate 
in the daughter branches requires knowing many parameters such as the angle between the 
branches and also knowing the flow resistance all the way to the capillary bed [34]. For finding 
this ratio in our model, the resistance of the all vessels was found and using the electric circuit 
analogy [43], the flow in all branches was calculated. 
The next level in the vascular system following the arterioles is the capillary bed. In our model, 
for implementing the capillary bed, certain assumptions have been made: First, it is assumed that 
every section of the capillary bed is fed by only one arteriole and the efferent blood from each 
section is collected by only one venule. Next, it is assumed that flow in the capillaries is not 
laminar but in the form of plug flow. In this case, no dispersion due to laminar flow would be 
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seen in these microvessels. The capillary bed can be considered as a network of microscopic 
vessels that form a grid. The whole capillary network between the arteriole and venule has been 
modeled as a single vessel of larger diameter with non-laminar flow. This will basically cause 
only a delay in the flow of blood entering the veins and venules. However, when estimating the 
TIF in images, one consideration should be the possibility of sampling from an area where the 
capillaries are being fed from more than one venule and the resulting signal being the result of 
CA profiles; this condition will be addressed later in the following sections, when model 
averaging technique is discussed. 
 
Figure 2.6. Morphological structure of the vascular model; branching of arteries and arterioles has been done down to six 
levels. As seen here, the veins and venules have a larger volume and diameter compared to arteries and arterioles. The 
volumetric flow rate of blood entering this model equals the efferent flow. Every segment of the capillary bed is modeled 
as a single tube vessel in which the flow is non-laminar. 
The diameter of venules and veins that return the blood from the capillaries is large enough to 
have flow in laminar form in them. Therefore, the transfer function of these vessels is similar to 
the arteries. However, one point that has been considered in our model is the larger diameter and 
overall luminal volume of the veins and venules compared to the arteries and arterioles. The 
overall volume of veins and venules is about 4 times that of arteries and arterioles [34]. This is a 
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natural effect for dealing with the pressure drop of blood after passing through the arteries and 
capillaries.  
2.3.3 Transfer Function of the Brain Vascular Ensemble 
The next step in implementing the vasculature model is finding the transfer function of the 
vessels between the input artery and nodes in the structure. This is done by combining the 
transfer function of the single vessel and the overall structure of the vessels which we introduced 
in the previous two sections.  
Equation 2.11 shows the transfer function of a single vessel. In the situation that there is a 
cascade of vessels, the overall transfer function of the vessels from the input node to any node in 
the system would be the convolution of the transfer functions of the individual vessels to that 
node. In this case the transfer function of each vessel can be written as follows: 
(2.16)       
   
  
                
(2.17)        
   
       
                     
(2.18)        
   
           
                           ………. 
(2.19)       
   
                   
                                             
In these functions,     to     are the time delays of each individual vessel along the branching 
route, from the opening of the main artery down to the n
th
 branching layer. The transfer function 
of the vessels from the input to the n
th
 level of sub-branches is:  
(2.20)                                  
 
It should be noted that when calculating the transfer function of the cascade of the vessels, the 
delay of the transfer function of each segment will be calculated independent of the common 
time origin and the equation will be similar to the equation of the first segment but with the    of 
that segment. After implementing the vascular model described in section 2.1.2, by assigning a 
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flow to the input artery, the flow to all the vessels in can be found. This, along with the physical 
characteristics of the vessels in the model can all be used to find the parameters of the transfer 
function (which are basically the time delays of the segments). Figure 2.7 shows the transfer 
functions between the opening of the main artery to the end of each of the vessels in the vascular 
structure, down to the sixth layer of branching in one vascular line. The gain of these transfer 
functions are arbitrary and the area under all these curves have been normalized to a common 
value. As seen here, as the level increases, the transfer function gets more spread out in the time 
domain and also the arrival time increases. The arrival time actually represents the time delay of 
the vessel. 
 
Figure 2.7. The transfer function of vessels from the opening of the main artery down to the 6th level of the vascular 
branching.  As seen here, as the level increases, the arrival time and dispersion both increase. The total delay time at the 









TESTING THE VASCULAR MODEL WITH DCE IMAGING 
The next step in the vascular model development was testing the model. For this purpose, a 
modality of dynamic imaging was needed for investigating the changes of the CA concentration 
profile in main arteries and tissue and to use them to find the transfer function that relates them 
and try to match that with the parameters of the transfer function of our model. In this chapter, 
first we will describe our methods for finding the vascular branching level of a CA profile.  And 
next, we will test these methods on simulated data and data from human studies.  
3.1 Steps for Finding the Vascular Branching Level from the CA Profile 
Our goal here is to test the model and the transfer function that were introduced in the previous 
chapter. We present a platform here, to estimate a transfer function, that when presented with a 
global AIF and the CA profile of any voxel in a DCE image series, it would give an estimate of 
the level of that voxel in the vascular tree of the brain. The main blocks of this platform are the 
fitting and the model selection methods. 
3.1.1 Fitting the Models to the Data.  
Every voxel in the image volume belongs to one part of the vascular tree or the capillary bed; 
however, except for a few major vessels, it is not visually possible to follow the level of vessels 
in the branch hierarchy. The goal is to determine the likelihood of each voxel belonging to 
different branching levels of the vascular tree structure. The first step is estimating a transfer 
function which when convolved with a global AIF, can result in the CA concentration profile of 
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a voxel (Figure 3.1).  
 
Figure 3.1. System for finding parameters of the transfer functions that transform the AIF to the TIFs that are measured 
for every voxel in the brain. 
It should be noted that            denotes the transfer function between the main artery and only 
one branch at the n
th
 level; however, when the branching level increases, the diameter of the 
branches get smaller and the intensity of the signal from each single branch decreases.  When the 
signal is sampled in an image, many branches may fit in an area the size of one voxel. To 
compensate for this fact, a gain factor  , was added to the transfer function. The new equation of 
the transfer function can be written as: 
(3.1)                                     
This equation shows the general expression for           , the transfer function between the first 
and the n
th
 level of branching. The global AIF profile is defined as        and the tissue input 
function in an arbitrary voxel in the brain image as       . The relationship between these two 
can be defined as: 
(3.2)                                          
where x is the branching level of the vessels at that voxel which generally speaking, is initially an 
unknown value and the goal is to determine the possible value (or values) of x for that voxel.   
Prior knowledge about the cerebral vascular anatomy and morphology of the cerebral vascular 
trees can help find the limit on the number of branching levels in our model. The three main 
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arterial branches originating from the circle of Willis are the Anterior Cerebral Artery (ACA), 
Middle Cerebral Artery (MCA) and Posterior Cerebral Artery (PCA) [35] as seen in Figure 2.2. 
Each of these major vascular trees feeds a different part of the brain, but since they all originate 
from the circle of Willis, considering the relatively low time resolution of the imaging 
modalities, it is assumed that the CA profile in the blood entering these three branches is the 
same. Wright et al. have done a comprehensive measurement and morphology analysis of human 
brain arterial vasculature using Magnetic Resonance Angiography (MRA) among 61 health 
volunteers [36]. According to their measurements, the maximum number of bifurcations in the 
three vascular trees are 6.15 ± 1.53 (ACA), 8.80 ± 1.40 (MCA), and 5.93 ± 1.66 (PCA). Based 
on these values, to find the branching level x, at each voxel, it is assumed to have any of the 
values from 1 to 6. According to equation 3.1,            is a function of n+1 parameters where 
    to     indicate the delay of every branch from the main artery to the n
th
 branching level and   
is a gain factor. 
Using the simplex method [44] as a non-linear fitting method and the sum of squared errors as 
the cost function, for every possible configuration of the transfer function (          ,            
,… or           ) as described by Equation 3.1, the best function that can transform the reference 
       to        is found. This results in six different sets of optimal parameters (each 
consisting of                    where n varies from 1 to 6). The next step is determining the 
best set of parameters among these six that can describe the transfer function between the main 
artery and that specific voxel. The order of this function can define the level of vascular 
branching in that voxel and the sum of the    parameters can determine the CA arrival time to 
that voxel. 
3.1.2 Model Selection and Model Averaging Using Akaike Information Criterion (AIC)  
After finding the six best transfer functions (one for each of the one to six branching layer 
configurations) or models for every voxel, the problem of determining the contribution of each 
model needs to be addressed; this is necessary since each voxel might be representing a 
combination of tissue or vessels (from different layers of the vascular structure); or if it is the 
representative of only one vessel or tissue type, the branching level of the vessel at that voxel 
needs to be estimated. Two methods that can be used for model selection and model averaging 
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are Akaike Information Criterion (AIC) [45]  and Bayesian Information Criterion (BIC). 
According to the principle of parsimony, if equal conditions exist, the model with lower number 
of parameters should be selected over more complex ones. Both of these methods satisfy this 
principle by penalizing the models by the number of parameters.  One of the advantages of AIC 
over the BIC is the fact that AIC penalizes the number of parameters less strongly than BIC [46] 
and since one of the main distinctions between the different models here is the number of 
parameters, results would have been more biased towards the lower level models if BIC was 
used. Considering these facts, the AIC method was used to find the goodness of fit of these 
models. 
In the general case, for a statistical model, the AIC value is defined by: 
(3.3)               
where k is the number of parameters of the model and L is the maximized value of the likelihood 
function of that model. AIC can also be calculated using the residual sums of squares: 
(3.4)            
   
 
  
As a rule of thumb, if  
 
 
   , bias adjustment needs to be done and AIC will be calculated 
as[46]: 
(3.5)         
      
     
      
   
 
  
n is considered to be the number of observations (or in our study, the number of timepoints), and 
is 99 for all models; k varies from 2 to 7 for models one to six respectively. The AIC values for 
these five models are named AICi where i=1 to 6. The best fit model is the one with the lowest 
AIC value which we name AICmin. The goal is to find the likelihood of each of these six models 
being the best fit model for every voxel. To find these likelihood values, the Akaike weights are 
estimated. First a new variable    is defined that represents the difference between the AIC 
values in these six models with the lowest AIC value: 
(3.6)                                         
Using    the Akaike weights are calculated as: 
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(3.7)     
            
∑             
 
   
 
   is considered to be the probability of model i being the best model that describes the transfer 
function between the main artery and the voxel being studied.   
3.1.3 Delay maps 
As explained in section 2.1.1, every transfer function is described with a set of 
parameters                 . In this set, every    represents the shortest time that blood takes to 
pass through the vessel segment; or in other words, it is the time that the fluid flowing with the 
velocity on the central axis (maximum velocity of the laminar flow) would take to pass through 
that particular vessel branch. In the case of dealing with only one model, by adding all these     
values from the best fit transfer function from that model, the total delay time from the main 
artery opening to the voxel being studied (or the arrival time of the contrast agent for that voxel) 
can be calculated; however, in this study since multiple models are used, the delay time of each 
voxel is estimated by calculating a weighted sum of the delay times of all models, with the 
weights being the Akaike weight or the likelihood of each model being the best fit model for that 
voxel: 
(3.8)         ∑   
 
    ∑    
    
    
Where    
  is the    of model i at the j
th
 level of branching. The benefit of using this model 
averaging method [47] for calculating the delay time is that voxels  representing tissues that are 
being supplied by more than one branching level of the vascular system will have all those 
vessels accounted for and the delay time will be a weighted average of all the possible delay 
times from different vascular pathways.   
3.2 Simulation results 
Prior to applying our method to human data for estimating the vascular transfer function in these 
images (as explained in section 3.1.1), a simulation of the blood flow in our vascular model was 
performed to explore the feasibility of using this method for estimating the vascular transfer 




3.2.1 Simulating the Size and Flow Rate of the Model Based on Real Life Measurements 
The first step in our analysis was designing the model with sizes comparable to real life values. 
The diameter of the common carotid artery in healthy adults has been estimated to be [48] 6.0 ± 
0.8 mm and the mean diameter of the  ICA  has been measured to be  4.66± 0.78 mm and  
5.11±0.87 mm in women and men respectively [49]. The mean velocity of blood passing through 
the Internal Carotid Artery (ICA) and Middle Cerebral Artery (MCA) has been measured to be 
32.7 ± 3.0 cm/s and 58.1 ± 8.6 cm/s respectively in normotensive adults [48]. These values were 
used as the starting points of our model implementation. Based on the findings of Wright et al. 
the mean and standard deviation of the branch lengths in the brain is 25.02 ± 2.71 mm (19.35 
mm-30.14 mm). To find the radii of the sub-branches of each branch, we randomly selected the 
radius of one of the sub-branches a value between 0.77×R and 0.83×R (where R is the radius of 
the mother branch) and the radius of the next one was calculated based on Murray‟s law 
(Equation 2.12). The length of the main branch of our model was set to 4 cm based on these 
reported values.  As the length of every sub-branch, we assigned a random value from 50% to 
70% of the length of its mother branch.  Using these initial values and branching rules, our 
model was implemented with six levels of branching as in Figure 2.6 down to the capillary level 
and the veins and venules were implemented as the mirror image of the arteries and arterioles, 
albeit with a larger diameter to compensate for the pressure drop along the vessels. The flow in 
every vessel in this model was calculated by finding the resistance of every branch based on 
Poiseuille‟s law [34] and by converting the model to an analogous electric circuit and finding the 
electric current  in all branches based on Ohm‟s law [43].  
It should be noted that when finding the flow values in the branches, we assume a steady blood 
flow in all branches which does not change with time, neither locally nor globally. After finding 
the blood flow of all branches in the model, the time delay (  ) of each branch was calculated 
based on Equation 2.6. Next, a node was randomly selected on the sixth level and the time delay 
of all the branches connecting the main artery to that node was found; using Equation 2.20, the 
vascular transfer function between the opening of the main artery and every node was estimated.  
Using the profile of the contrast agent in the carotid artery of a human subject in a CT-DCE 
image (Which will be described in detail in section 3.4) and the six transfer functions between 
the main artery and every node in the pathway described above, TIF at every node was 
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calculated by convolving this AIF with each transfer function. Figure 3.2 shows the AIF and the 
TIFs at the six levels. For better visual comparison of these curves, the peaks are all scaled to the 
same level as the AIF. As seen here, by moving to higher levels of the vascular tree, the arrival 
time of the CA profile increases and it gets more dispersed. By creating these TIFs, our goal was 
to: 
 (1) Explore the feasibility of our method for determining the level of the a TIF based on the 
transfer function that transforms the AIF to it and  
(2) Test our method for separating the TIFs from two different levels when added together to 
form a composite signal. 
 
Figure 3.2.  Plots of the main AIF (bold curve) of a human subject along with the TIFs at six levels of our vascular model. 
These are estimated by convolving the main AIF with the transfer function at each level. The AIF was sampled from the 
first 45 seconds of the DCE-CT image series in the voxels showing the Internal Carotid Artery of a human subject after 
the bolus injection of the CA.  For easier comparison of the profile of these curves, the peaks are scaled to the peak of the 
AIF. As seen here, by moving to the higher levels of the vascular structure, the arrival time delay gets longer and the 





3.2.2 Estimation of the Branching Level of the Simulated TIF  
The goal of the first part of our simulation was to explore the ability of our method for finding 
the correct transfer function of different nodes in the vascular structure, based on the AIF and the 
simulated TIF‟s based on the method explained in 3.1. Using the fitting procedure in 3.1.1 and 
the model selection method in 3.1.2 the different models were fit to each of the six TIF‟s and 
using the residue and the Akaike method, the likelihood of these TIF‟s belonging to each of the 
different models was estimated.  This simulation was repeated by adding different levels of noise 
to the TIF‟s. Figure 3.3 shows the results of this simulation. As seen here, the added noise level 
is varied from 0% to 100% and at each of these levels, the likelihood of selecting the correct 
level of the vascular structure has been estimated. Up to 18% of noise level, the likelihood of 
picking the correct level of the TIF is almost 1 for all cases. As the noise level increases, the 
accuracy of the system decreases and the likelihood of picking the correct model is reduced; 
however, in the 100% noise level, the probability of picking the correct level index does not go 
below 0.45.  
3.2.3 Decomposing the Simulated Composite TIF 
In real applications, when the CA concentration profile is being sampled from a typical voxel in 
a DCE image series, considering the size of the vessels and the complexity of the vascular 
network in the brain, it is very likely that each voxel would be representing a composite of vessel 
segments, originating from more than one level of the vascular tree. As will be explained in 
section 3.4, when applying our method to the DCE images, this fact has been considered and the 
likelihood of presence of different levels of the branches of the vascular tree in each voxel is 
estimated. To explore the feasibility of this method for finding the likelihood of presence of 
signals from each level of the vascular structure, the superposition of the CA profile from two 
levels of the model was simulated and in the next step decomposed by the fitting algorithm and 




Figure 3.3.  Akaike weights of each of the simulated signals after model averaging. The plots show the likelihood of each 
of the simulated TIF's being selected as the level of branching that they were simulated for. As seen here, even at the 18% 
noise level, the likelihood of picking the correct branching level of the TIF is almost 1 for all cases. As the noise  level 
increases, the accuracy of the system decreases and the likelihood of picking the correct model gets less; however, in the 
100% noise level, the likelihood of picking the correct level index does not go below 0.45. 
Figure 3.4 shows a schematic diagram of our vascular model simulation. Here, the AIF is similar 
to the AIF used in the previous section and the TIFs from the second and sixth levels are found 
by convolving this AIF with the vascular transfer function at these two levels. The square 
represents a hypothetical voxel in which vessels from both the second and sixth levels pass 
through. The temporal signal sampled in this voxel is the weighted sum of the signals from the 
two vessel segments and depending on the effective volume of each of them in this voxel, the 
level of contribution of each signal will be adjusted. In our simulation, it is assumed that the 
weighted sum of only two signals from any two levels are present in the hypothetical voxel and 
the level of contribution of each of these two can vary from 0% to 100%, meaning that the signal 
is fully representing one level or the other or a combination of them. In addition, we added 
different levels of noise to the composite signal (0% to 100%) and explored the feasibility of our 




Figure 3.4. Schematic figure showing a typical AIF from the carotid artery of a human subject in DCE-CT images and the 
simulated TIFs at the second (L2) and sixth level (L6) of our vascular model. In this figure the effect of one voxel 
representing vessels from two different levels has been simulated. In this case the signal sampled from this voxel would be 
the superposition of the two signals (L6+L2). Using this configuration, we have studied the feasibility of our method to 
distinguish and separate the signals that form the composite signal. 
Figure 3.5 shows the curves representing the Akaike weights of the composite signals after 
decomposition by the method explained above.  Each curve represents the average of results 
from 300 repetitions at each noise level. The composite signal is basically the weighted sum of 
the two signals as described above each curve (the x-axis represents the percentage of 
contribution of the second signal in the composite signal based on their energy level).  As seen 
here, in noise levels lower than 50%, all these curves meet at the 50% contribution point which 
matches our expectation: when the composite signal is the sum of two signals with equal levels 
of power, our method is able to decompose them into two signals with equal weights for each 
signal. One observation in these curves is that in the cases that there is no noise added to the 
signals or the noise level is small, the Akaike weights tend to get saturated to 1 or 0 for the 
individual signals, when the contribution is not close to 50%. This is due to the large difference 
in the residue values of the fitting procedure for the two signals in the absence of noise; when the 
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level of contribution of one signal to the composite signal changes from 0% to 100%, the residue 
increases in the order of 10, which is roughly what the difference between the residue of the 
fitting procedure for the two signals is when the contribution level of one is 0% and the other is 
100%.  This causes the AIC value to have a difference of approximately 250 between these two 
signals which leads to the Akaike weights calculated by Equation 20 have the values of 0 and 1 
for these signals. As a rough rule of thumb, if the difference between the  AICi  or the AIC of 
model i and AICmin is between 0 and 2 , the level of empirical support for model i is substantial 
and if it is  between  4 and 7 it is  considerably less and if  it is  larger than it is 10 essentially 
none [46].As the contribution of the second signal increases, the residue values for the two 
models get closer and fall in the same order; therefore the Akaike weights will have values 
between 0 and 1, as seen in the points of the curve close to the 50% point. When noise is added 
to the composite signal, even for the case of pure signals in the original composite signal, the 
residues will have large values and they will vary much less than what is seen in the no-noise 
situation and therefore the Akaike weights will  not get saturated in these cases. It should also be 
noted that when the difference between the levels of the two signals increases, this saturation 
effect will become more evident, even in the presence of noise.  The worst case is when one 
signal is from the 1
st
 layer and the second is from the 6
th
 layer, as seen in Figure 3.5. This is due 
to the large difference between the two residue values of these two signals after the fitting 
procedure. If a measure for the level of contribution of the signals is sought, using variations of 




Figure 3.5. Akaike weights of the simulated composite signals after decomposition.  Each curve represents the average of 
results of 300 repetitions at each noise level. The composite signal is basically the weighted sum of the two simulated 
signals (the x-axis represents the percentage of contribution of the second signal in the composite signal) from different 
layers of the vascular structure.  In each of the boxes above, each plot represents one noise level: In the upper half of the 
box, from left to right, each dotted line indicates 0% to 100% noise level (0%, 1%, 4%, 10%, 18%, 28%, 37%, 52%, 
75%, 94%, and 100%) added to the composite signal and the solid lines correspond to %100 to %0 noise levels 
respectively. In the absence of noise, the switching point for all of these cases occurs at the 50% level which is what is 
expected. However, in the case that the model levels are consecutive, when the noise level is increased, this switching point 
moves towards higher values, in favor of the model with fewer parameters. The worst case is seen in level 5 vs level 6 





3.3 Modalities Considered for Testing the Model 
For testing the model, several dynamic imaging modalities were considered that could have 
satisfied the requirements of our model; however for practical reasons not all of these were 
suitable for this part of our study. These modalities were as follows: 
 - DCE-T1 Images 
 - Dual Gradient Echo Images 
 - Fluorescein Angiography of the Fundus 
 - Dynamic CT images of the Brain 
Below each of these modalities is described in more detail: 
3.3.1 DCE-T1 Images 
In DCE-T1 imaging, Spoiled Gradient-Recalled Echo (SPGRE) T1 weighted images are 
acquired repeatedly for a period lasting for a few minutes. The first few images are considered as 
the baseline and are recorded prior to injection of the CA. After intravenous injection of the CA, 
image acquisition will continue for a few minutes afterwards [50]. The contrast agents used in 
DCE-T1 imaging work by decreasing the spin-lattice relaxation time (or T1) in tissues that it is 
localized [51]. One of the most commonly used MR contrast agents is Gadolinium_Diethylene-
Triamine-Pentaacetic-Acid (Gd-DTPA) that produces a marked reduction in proton relaxation 
rates. Gd-DTPA does not cross intact Blood-Brain-Barrier (BBB) and rapidly gets eliminated by 
glomerular filtration in the Kidneys [52].  It is assumed that the dose (or concentration) of Gd-
DTPA is linearly related with the changes of the Spin Lattice Relaxation rate (Relaxitivity or 
1/T1) which is expressed with the 1/seconds unit [51, 53]. However, nonlinearities in changes of 
relaxitivity (or in other words ∆R1) due to limited access of water in tissue compartments distal 
to the CA can substantially bias estimates of tissue CA concentration. In addition to the non-
linearity problem, in MR fast sequences, the T2* contrast competes with T1 contrast and can 
bias the estimate of T1 and consequently ∆R1 [54]. Since our goal was to test our model in 
different parts of the brain and different levels of the vascular structure, these nonlinearities and 
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also the T2* effect would have caused unreliable results and therefore we decided not to use this 
modality for this part of our research.  
Inversion recovery imaging techniques such as the Look-Locker (LL) pulse sequence can offer 
unbiased estimation of longitudinal relaxation time (T1) and the LL pulse sequence shows no 
evidence of bias in its estimates of tissue CA concentration [55]. However, LL imaging is a slow 
imaging technique due to the time required for full recovery of the longitudinal magnetization 
between sequential inversion pulses. 
3.3.2 Dynamic Dual Gradient Echo Images 
Spoiled Dual Gradient Echo (DGE) pulse sequence is a fast imaging technique with short echo 
time and relatively short time interval between image acquisitions (2 to 4 sec). The main 
advantage of DGE imaging is that it allows computation of T1 and T2* as pure components: this 
is essential for estimation of CA concentration (ΔR1 and ΔR2*) for both permeability and 
perfusion studies. However, in practice the complex relationship between signal intensity, T1, 
T2*, and other model parameters such as M0 and flip angle, makes the dynamic estimation of 
ΔR1 in the presence of noise levels typical of MRI, quite challenging [56]. We have developed 
novel methods for estimation of ΔR1 and ΔR2* signals in these images which will be described 
in detail in chapter IV. Despite the advantages of this image modality, the human images that we 
had acquired were too noisy and we decided not to use them for this section of our experiments. 
3.3.3 Fluorescein Angiography of the Fundus 
Fundus Fluorescein angiography (FFA) is an optical imaging method that is used for studying 
anatomic structures of the ocular fundus. The fundus is the interior surface of the eye and 
includes the retina, optic disk, macula and fovea and is the only part of the mammalian body 
where microcirculation can be directly observed [57]. Fluorescein Angiography records the 
dynamic interaction of fluorescein with both normal and abnormal anatomic structures of the 
ocular fundus. This procedure is performed by injecting fluorescein sodium dye as a bolus into a 
peripheral vein and recording the retina images using a fundus camera. The angiogram is created 
by imaging the fluorescence of the dye (520–530 nm, green–yellow light) after the retina is 




Figure 3.6. The four main stages of a fundus angiogram in the vessels of the Retina of a rat, seconds after injecting the 
fluorescein (A) shows the “Choroidal flush” stage where the fluorescein leaks into the extravascular space of the chorio-
capillaries (B) The “Arterial phase” happens two seconds after the choroid is filled. As seen here the arteries start filling 
in this stage(C) In the “Arterio-venous phase”, after the blood containing the CA passes through the capillaries, it gets 
collected by the veins; as seen here the effect of laminar flow can be seen as the layers of fluid closest to the vein walls get 
filled faster (D) Finally in the “Venous phase”, filling of the veins gets completed. 
Figure 3.6 shows FFA images from the retina of a rat that were acquired as part of a research 
study at Henry Ford Hospital to investigate the effects of Diabetes on microvasculature. The 
main goal in this experiment was measuring the circulation time of the CA from the arteries to 
the veins in normal and diabetic animals and based on that study the changes in the microvessels 
due to the disease. In this figure the four major stages of FFA can be seen. These are the 
Choroidal flush, Arterial Phase, Arterio-venous phase and the Venous phase. The profile of the 
contrast agent is measurable by sampling the pixel at different locations of the image. One 
advantage of this method is the high temporal resolution of the images (32.25 ms) 
Even though this could have been an ideal modality for testing our model, we were not able to 
use these images due to problems including saturation of the CA signal after the filling of the 
major vessels and also excessive shifting of the images due to movement of the eye and not 
being able to co-register the images in a reasonable manner. Also, the number branching levels 
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and vascular physiology in the retina are not necessarily similar to those of the brain but we for 
testing our model, we could have adjusted the parameters to match the ocular vessels.  
3.3.4 Dynamic CT Images of the Brain 
Compared to DCE-MRI, DCE-CT images have lower Signal to Noise Ratio (SNR) and Contrast 
to Noise Ratio (CNR) [59] however, several other characteristics of this modality made it an 
attractive choice for our study: The signal intensity of the CT images is linearly dependent on the 
CA concentration [60] and also, the temporal resolution of this modality is much higher (~10 
times more) than DCE-MR images (0.5 sec vs. 5 sec). In addition, CT images have a better 
spatial resolution [61]. All these characteristics made DCE-CT imaging an attractive candidate 
for our study. 
3.4 Testing the Model with Dynamic Contrast Enhanced Computed Tomography 
(DCE-CT) Imaging 
After studying different dynamic imaging modalities mentioned above, DCE-CT images were 
selected as the modality for testing our model.  Below, the steps of processing these images for 
testing our model will be described. 
3.4.1 CT Image Acquisition  
DCE-CT images were acquired on a GE LightSpeed VCT scanner with image matrix size of 
512×512 (24×24 cm FOV) and eight slices (5mm slice thickness) with 99 imagepacks (89 image 
sets sampled every 0.5 seconds for the first 44 seconds, one image acquired at the 50 second time 
point, followed by 9 image sets acquired every 16 seconds for a total scan time of 194 seconds). 
50ml of iodinated CA with a concentration of 0.5ml/Kg was injected as a bolus using a power 
injector at a rate of 4cc/sec starting five seconds after start of image acquisition; cine scan was 
done for 50sec.  
3.4.2 CT Image Preprocessing  
The dynamic images were baseline corrected to make their intensity linearly dependent on the 
CA concentration. Also, to increase the SNR, especially in the tissue regions, the neighboring 
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voxels were averaged and the images were downsized to 128×128. After these pre-processing 
steps, the CT images were ready to be used for testing the model. 
3.4.3 Results of Applying the Model to DCE-CT Images 
For every subject, a small region on the circle of Willis was sampled and the temporal signals 
from the voxels in this region were averaged to represent the global AIF. This AIF was used as 
the reference for all the brain voxels for that subject. 
The temporal DCE-CT data of every voxel was sampled and based on the method described in 
section 3.3.1, the six different transfer functions were convolved with the global AIF to find the 
best fit to the signal for each configuration. Using the fitting residues for every voxel, the Akaike 
weights were calculated. By assigning the Akaike weights of every voxel to the corresponding 
voxels in six image volumes, the probability maps of these six models are estimated. Figure 3.7 
shows these six probability maps for two slices of a DCE-CT image volume. These show the 
probability of every voxel belonging to the each of the six models.  As seen in this figure, in the 
probability map of the first model, the voxels that represent the major artery that the AIF has 
been sampled from have the highest Akaike weight which has a value very close to 1. As the 
model index increases, the voxels with the highest value shift from the major arteries to the 
veins. In the map corresponding to model 6, the voxels showing the major veins such as the 
sagittal sinus and the tumor have the highest likelihood of belonging to this model. These 
probability maps are used to create the blood flow delay maps of the brain. 
One point that should be mentioned about the Akaike-weight maps in Figure 3.7 is the values in 
the normal tissue areas. Here, originally, the highest Akaike weight value of these voxels 
occurred mostly at model one (with a value of around 0.5) and the next two levels of maps had 
Akaike weights that were less than this value but were still considerable. Considering the 
hierarchy of the vascular structure, we didn‟t expect these voxels to have high Akaike weights 
for models with lower index. The reason was that after fitting the different levels of the models 
to the signals from these areas, models five and six had the best fit (had a lower residue after 
fitting) but not considerably better than the other models . One reason that the residue values of 
fitting are not dramatically different between different models in these areas is the low Contrast-
to Noise ratio in normal tissue due to the small intravascular plasma volume fraction in normal 
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tissue which is less than 1%. Also the non-leaky property of intact vasculature in the brain 
contributes to this low contrast to noise ratio in these areas. Therefore these areas have a low 
CNR and the signal due to the CA is very noisy. After calculating the AIC values based on 
equation 3.5, since the number of parameters (k) for the first model was much lower than model 
six (2 parameters  vs. 7 parameters), the estimated AIC values for voxels in this region got biased 
in favor of the lower models which is one of the characteristics of the AIC method. If the AIC 
gets calculated without the applying the penalizing terms (the number of parameters in the model 
for each level), the Akaike weight order for different models will follow the order of the fitting 
residue values for each level. One solution to this problem was to average the temporal signals of 
the neighboring voxels with low intensity prior to estimating their transfer function. This will 
reduce the noise and can result in a lower residue for the best fit model. We applied this solution 
to these images and got the results as seen in Figure 3.7. In this figure, the contribution of the 
higher level models to normal tissue can be seen after spatial averaging of the neighboring 
voxels. 
Figures 3.8-a and 3.8-b show the delay (arrival time) maps of the same slices of the DCE-CT 
image set as in Figure 3.7. These delay maps are created after model averaging. What these delay 
maps show are basically the arrival time of the CA at different points of the image, with respect 
to the arrival time in the Circle of Willis, where the AIF has been sampled from. In the CT 
images, the major vessels (arteries and veins) can be seen with a higher contrast but in the delay 
map the arteries have a lower intensity since the delay time is shorter in them; however, the veins 
such as the inferior and superior sagittal sinuses show the highest delay time in these images and 
have values above 4 seconds which is a good approximation of the mean transit time of the blood 
flow in the brain [62]. Point R in this figure shows the reference point where the global AIF was 
sampled (similar to the AIF profile as in Figure 3.1). This AIF was used to estimate the transfer 
function between R and all the voxels in the image. As seen here, the estimated delay time is 
different at different parts of the brain: The arteries such as the main arteries marked as A have a 





 Figure 3.7 . Akaike weight (likelihood) maps of two slices of the CT image based on the six levels of the vascular tree 
model. The intensity of each voxel in the images L2 through L6 images show the likelihood of that voxel belonging to that 
level in the vascular tree. Based on the Akaike method, the sum of the intensities of every voxel across the six images is 
one. The images on the right column are the CT images of the same slice, a few seconds after injection of the contrast 
agent. As  seen in these CT images, all the major vessels have been enhanced in intensity but there is no distinction 




Figure 3.8. (a),(b) Two sections of post injection CT images and  (c),(d) the delay (arrival time) maps (in seconds) created 
using the parameters found by our method. „R‟ is the reference point for measuring the glocal AIF. „A‟ is the location of 
one of the main arteries (short delay) and „B‟ shows the Superior Sagittal Sinus (long delay). „T‟ shows the location of the 
tumor. 
One important note about this figure is the part of the image where a tumor can be seen (T). 
Based on the estimation using our method, the delay (arrival) time of the tumor in this image is 
long and comparable to the major veins such as the sagittal sinus. The artery or arteries that feed 
this tumor are not known to us at this point and we cannot make a statement about the level of 
their branching level (which could be from a higher level); however, the main reason for the 
system identifying this structure as having vessels from a high branching level is the abnormal 
CA profile sampled from this area in the CT images. Due to leakage of the CA from tumor 
vessels into the extravascular space, the CA profile does not follow the trend of the AIF sampled 
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from the major artery. Since the time required for the CA particles in the extravascular space to 
get cleared is usually longer than the imaging duration, the intensity of the voxels in these areas 
will stay high to the end of the scan. Therefore, the CA profile of these voxels mimics profile of 
a highly dispersed AIF. Although our method will still not be able to find a good fit to these 
profiles using the dispersed AIF found by model in its current form, it finds the best fit by 
assuming the TIF is from the 6
th
 level. In the following chapters, we will introduce an extended 
version of our vascular model where leakage of the contrast agent is also included in the model; 
there we will look more closely at the profile of the contrast agent and how to separate the 
intravascular and extravascular components of the tissue response signal in these areas. 
3.4.4 Software Platform for Processing the CT Images  
A software platform was designed and developed in MATLAB to perform the steps above and 
create the delay maps from the DCE CT images. Figure 3.9 shows the main interface of this 
software. Four dimensional DCE-CT images are read into the software in DICOM format and 
the user can go through different time points or slices of the image volumes using the scroll bars 
and can also adjust brightness or contrast of the images to find the best location for sampling the 
AIF from a major artery in the left window and have it plotted in the window on the right. 
Baseline correction is done after the CA profile is plotted and two baseline timepoints are 
selected using the scroll bars beneath the right side window. Reduction of the image size can be 
done before or after baseline correction. After baseline correction, the CT image intensity is 
assumed to be linearly dependent on the CA concentration. Figure 3.9 shows the CA profile of a 





Figure 3.9. The main interface of the software platform for pre-processing and processing the CT images for estimating 
the level of the vascular tree in each of the voxels in the image. The image in the window on the left shows one slice of the 
baseline corrected CT image and the plot in the window on the right shows the CA profile sampled from a small region on 
the circle of Willis. As seen here, since this image is baseline corrected, the intensity of the image prior to injection of the 









CALCULATION OF THE VASCULAR PERMEABILITY AND 
PERFUSION PARAMETERS  
In this chapter, we will describe the theory, methods and a software tool that we have developed 
for estimation of the permeability parameters using Dynamic Contrast-Enhanced MR images and 
in the next chapter, will use these concepts for describing an extension of our vascular model 
which can describe the flow and vascular branching in vessels with leakage.   
4.1 The Indicator-Dilution Method 
The concept of Dynamic MRI started in the mid 1980‟s after injection of a contrast agent was 
proposed for measuring perfusion in tissues and permeability in vessels [40]. These 
measurements are based on the concepts of the Indicator-Dilution method introduced in the 
1950‟s [12]. To use this method for Dynamic MRI, the concepts had to be translated to the MRI 
modality.  In this section, after introducing the Pharmacokinetic model, we will explain the 
Observation equation for DCE MRI.  
4.1.1 The Pharmacokinetic Model 
Modeling leakage in the vascular system in integral form was first generated by Patlak [63, 64] 
and reiterated by Tofts et al. [65]. The first Model developed by Tofts was simply named Tofts 
Model or TM and was developed by generalizing existing models of tissue that assumed 
negligible amount of intravascular CA in them and was written as:  
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(4.1)         
                 
where Cp(t) and Ct(t) are the plasma and tissue concentrations of the indicator, K
trans
 is the 
unidirectional transfer rate constant of the indicator from plasma across the vascular endothelium 
and blood-brain barrier into the interstitial fluid and kb is the transfer rate constant from the 
interstitial compartment to the vascular compartment. Since the assumption of negligible 
concentrations of intravascular CA was invalid, later TM was generalized to the Extended Tofts 
Model (ETM) as we use it today [33].  Based on the Extended Tofts Model, after intravascular 
administration of CA, its concentration in tissue is given by: 
(4.2)         
     ∫                 
 
 
         
Here, vp is the fractional volume of the vascular distribution space, usually thought to be the 
plasma distribution space.   
If the transvascular transfer of the CA is passive (non-active transfer), the two rate constants are 
related via the interstitial volume fraction: 
(4.3)    
      
  
 
It should be noted that in the computation of the permeability parameters, ve is a derived factor; 
kb is the parameter that can be directly estimated from the concentration-time curve. In section 
4.4, the details of our method for finding the permeability parameters using this model will be 
discussed. 
4.1.2 The Observation Equation 
It has been shown that the changes in Gadolinium (Gd) concentration and the longitudinal 
relaxation rate (= 1/T1) are related through the following equation [51, 53]:  
(4.4)                     
where R1 is the longitudinal relaxation rate (= 1/T1), R10 is the rate before injection of Gd and r1 
is proton relaxivity i.e. the increase in relaxation rate per unit concentration of Gd (its in-vitro 
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value is 4.5 s-1mM-1). As seen here, the change in Relaxivity is linear with CA concentration.  If 
the relaxation rate is subtracted from the pre-injection relaxation rate, the difference would be a 
parameter which is linearly dependent on Ct(t), the contrast agent concentration. We will name 
this ∆R1.  Based on this definition, the following equation relates the MR parameters to the 
pharmacokinetic model: 
(4.5)                                




This is named the Observation Equation. Here, Hct is the Hematocrit ratio, R1a has been defined 
as the longitudinal relaxation rate in the artery, and R1t as the longitudinal relaxation rate in the 
tissue, and Δ denotes the subtraction of the pre-contrast and post-contrast values of the 
longitudinal relaxation rate.  
4.2 Calculation of the Longitudinal Relaxation Rate Change (∆R1) 
Based on the Observation Equation, to find the permeability parameters of brain vasculature 
using the Pharmacokinetic Model and MR images, it is necessary to calculate ∆R1 first. We have 
used two MR sequences for permeability studies: Spoiled Gradient-Recalled Echo (SPGRE) 
DCE-T1 and Dual Spoiled Gradient Echo (DGE). In the next two sections, we will describe each 
sequence and explain the procedures that we have developed for calculating ∆R1 for these two 
sequences.  
4.2.1 Calculation of ∆R1 in DCE T1 Images 
In an SPGRE DCE-T1 sequence, the signal intensity of any voxel can be written as follows [66, 
67]: 
(4.6)        
         
     
                 
                  
 
Here, n is the index of the image in the DCE-T1 procedure, t is time, M0 the magnetization of 
protons in the voxel, θ the local tip-angle, TR the repetition time between the pulses, TE the echo 
time and   
     the transverse relaxation rate. Using this equation, we proceed to find ∆R1; the 




Figure 4.1. The profile of the CA sampled from the Left ICA in an SPGRE DCE T1 image series. The figure shows the 
timepoints m and n  where the preinjection signal is averaged from, for finding        for this signal. tn is the last time 
point before arrival of the CA to this point in the vascular structure. This image series consists of 70 timepoints with a 
resolution of 5.376 seconds. 
The typical time course of a DCE-T1 signal sampled from the ICA can be seen in figure 4.1. As 
seen here, the pre-injection and post injection phase of the signal can be clearly identified by the 
sharp rise at the arrival time of the CA. We name the last time point before arrival of the contrast 
agent tn. To define the mean of the signal before arrival of the contrast agent (µpre), two points 
are defined as m and n where m<n<tn: 
(4.7)        
∑   
 
   
     
 
Now we define a new parameter, αt, as the ratio of the baseline to post-injection signal intensity 
at any time t, where t>tn: 
(4.8)     




We can rewrite equation 4.6 with the pre-injection T1 and T2
*
 values as follows: 
(4.9)     
         
     
                       




Assuming that the errors in MRI tissue are approximately normally distributed µpre will be an 
unbiased estimator of S0: 
(4.10)         
Also, assuming that TE << T2
*
, αt in Equation 4.8 can be written as: 
(4.11)     
                                       
                                       
 
We define the following parameters: 
(4.12)                   
(4.13)                    
(4.14)   
   
  
  
                          
Based on these new parameters, Equation 4.11 can be re-written as: 
(4.15)     
                  
    
     
                 
 
Solving for   
 : 
(4.16)   
   
(    )             
  
                   
           
  
Therefore, the analytical equation for the change in R1(t>n) can be written as: 
(4.17)            
 
  
     
   
There have been other analytical estimates of R1 versus time after the injection of a CA such as 
the approach suggested by Li et al. [68] . However, the method suggested in that paper requires a 
priori knowledge of the relaxivity of CA in a particular tissue and also a measure of proton 
density (M0) must also be presented. It has been demonstrated [69] , that the apparent tissue 
relaxivity of a CA is dependent on the rate of transvascular water exchange, among other factors. 
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This exchange rate probably does change in pathology. The advantage of our analysis is that it 
does not require an assumption about the tissue relaxivity, or a calculation of M0, and may avoid 
systematic errors associated with an assumption as to the relaxivity of the CA in a particular 
tissue. The sensitivity of Equation 4.16 to a priori knowledge of the tip-angle (θ) should be also 
noted. 
4.2.2 Calculation of ∆R1 in Dual Gradient Echo Images 
As we mentioned in section 3.3.2, DGE imaging allows computation of T1 and T2* as pure 
components: this is essential for estimation of CA concentration (ΔR1 and ΔR2*). The ability to 
estimate pure components is an advantage to the SPGRE DCE-T1 images where nonlinearities in 
the MR measurement of ΔR1 due to limited access of water in tissue compartments distal to the 
CA  and also the T2* contrast competing with T1 contrast can substantially bias estimates of 
tissue CA concentration. Another advantage of the DGE sequence is the relatively short time 
interval between image acquisitions (2 to 4 sec).  Below we will describe the method we have 
developed for calculating the ΔR1 signal from the DGE signals. 
The following equations describe the measured T1-Weighted intensities of the first and second 
echo signals and their relationship with the longitudinal and transverse relaxation times (T1, 
T2
*
), repetition time (TR), echo time (TE), the flip angle (θ), and the equilibrium longitudinal 
magnetization (M0). F denotes the signal from the First echo and S the signal from the Second 
echo: 
(4.18)    
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(4.19)   
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(4.20)   
   
   
 
For each voxel there are two main phases for the signal: the pre-injection phase and the post 
injection phase. In order to set a baseline for the signal intensity prior to injection of the contrast 
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agent for each voxel, we average the signals     and    for that voxel over few time points prior 
to injection: 
(4.21)      
 
       
∑   
 
    
(4.22)      
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In this equation, t denotes the experiment time point and       and      are the mean of the 
signal intensities associated with first and second echoes between time points m and n where m 
and n are smaller than the injection time. Also we define      and      as: 
 (4.23)       
   
        ,        
   
         
 
Which are the values estimated using the images obtained from the T1 mapping sequences that 
are run before and after the DGE sequence. Using the definitions above, we have derived the 
following equations for preprocessing the DGE signals for Dynamic Contrast Enhanced 
Imaging: 
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As seen in these equations, we can get both an estimate for the pure component        and also 
the actual tip angle for the signal in each voxel. One interesting observation about this equation 
is that        is independent on the value of  
    . 
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Using this equation, and using the pre and post T1 values,        can be directly estimated. In 
our study, we  used  these equations, to train an adaptive neural network for estimating     maps 
in images of six Fisher rats with brain tumors [56]. The ANN was trained and tested with the 
DGE and LL information using a K-Fold Cross-Validation (KFCV) method with 60 folds and 
10500 samples. The Area Under the Receiver Operator Characteristic Curve (AUROC) for 60 
folds was used for training, testing and optimization of the ANN. After training and 
optimization, the optimal ANN (4:7:5:1) produced maps of CA concentration which were highly 
correlated (r =0.89, P < 0.0001) with the CA concentration estimated by the LL technique which 
are considered to be the gold standard for estimating the T1 value. The estimation made by the 
ANN had an excellent overall performance (AUROC = 0.870).  
4.2.3 Using Signal Intensity Instead of      
As we mentioned in the previous sections, the standard approach for solving the DCE 
pharmacokinetic model is creating an observation equation. It is generally assumed fact that the 
measured signal intensity (SI) time course data (St) be converted to an indicator concentration 
time course. The standard approach utilizes the longitudinal relaxation rate change (   ) to 
construct the concentration-time curve of the CA [70, 71]. This process depends on the accurate 
estimation of pre injection longitudinal relaxation times (T1) and signal intensity (S0) prior to 
administration of CA. Despite these approaches, there have been recent studies that have 
proposed to use normalized SI, (
     
  
  , instead of ΔR1 in DCE MRI permeability analyses [70, 
72]. However, we know of no assessment of the agreement in the estimated permeability 
parameters using different measures of CA concentration (SI, (ΔR1)).  Considering the fact that 
we use DCE-MR images in our study, it is of critical importance to address this issue before 
employing these images in any of our studies that involved testing our vascular models.  
Therefore we did two studies to evaluate the effect of using SI instead of ΔR1; In the first study 
we approached the problem in an analytical manner and using Equation 4.16, simulated the two 
signals and investigated the rate of change of ΔR1 value based on changes in normalized SI at 
different resting T1 values [73]. In the second study, we calculated the tumor permeability 
parameters using 3D Spoiled-Gradient-Echo (SPGRE) brain images of ten treatment-naive 
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patients with Glioblastoma Multiforme (GBM) using both SI and ΔR1 [74]. In chapter VI, the 
results of these studies will be presented. 
4.3 Estimation of T1 maps 
As explained in sections 4.2.1 and 4.2.2, calculation of ΔR1 requires knowledge of the T1 values 
of the tissue, prior to injection of the contrast agent [75]. Therefore one of the routine sequences 
in DCE MRI is the acquiring the Pre-Injection T1 map prior to acquiring the dynamic images. In 
this section, we will discuss the conventional methods for estimating these T1 maps and next, 
will introduce a novel method that we have developed for this purpose. 
4.3.1 T1 Map Estimation Using Conventional Methods 
Two of the most common methods for creating T1 maps are the Look-Locker (LL) [76, 77] and 
Driven Equilibrium Single Pulse Observation of T1 (DESPOT1) [78, 79] methods. LL is an 
inversion recovery method and DESPOT1 derives T1 from two or more spoiled gradient recalled 
echo (SPGRE) images acquired with a constant TR and different flip angles [75].  
Assuming that TE << T2* The SPGRE signal intensity can be written as [75]: 
(4.26)    
  (       
  
  
 )        
       
  
  
        
 
where M0 is the equilibrium longitudinal magnetization and    is the flip angle and i is the index 
of the flip angle. The goal is to estimate M0 and    using different fitting methods. Several 
methods have been proposed for this purpose such as Linear Least Squares (LLS), Gupta‟s 
Linear Least Squares (GLLS) ) [80], Nonlinear Least Squares (NLS) [81] and Weighted Linear 
Least Squares (WLLS) [81].   
As an example, the LLS approach estimates M0 and    by minimizing the following objective 
function [75]: 
(4.27)                  
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Where    is the expected signal standard deviation due to noise and n is the number of flip angles 
in the experiment. In the Linear methods, the equation is rearranged to form a linear equation and 
then, linear fitting methods will be applied to them for finding the values of       for each 
voxel. Estimation of T1 from the nonlinear SPGRE equation is susceptible to the signal 
acquisition noise level and also to the combination of the flip angles selected for the experiment. 
The problem with these linear methods is that they are not accurate in estimating T1, especially 
in regions with high T1, such as CSF. Overall GLLS and WLLS overestimate while ILLS 
underestimates [75]. Due to the inaccuracy of these methods, we decided to design a model 
trained adaptive system for estimating the T1 map based on the DESPOT1 method. The details 
are explained in the next section. 
4.3.2 T1 Map Estimation Using an Artificial Neural Network  
In this part of the study, the goal was to train an adaptive neural network (ANN) for estimation 
of T1 [76] to get better estimates compared to the conventional methods as explained in the 
previous section.  
In this study, two clinically approved SPGRE protocols with two sets of flip angles - [2 º, 5 º, 10 
º, 15 º, 20 º, and 25º] for the first study, and [3 º, 6 º, 9 º, 15 º, 24 º, and 35º] for the second study 
(N=1 to 6 for both sets) were used to model:  
(1) The signal acquired in the SPGRE MR experiments and 
 (2) a synthetic data set provided by QIBA (Quantitative Imaging Biomarkers Alliance)  
respectively.  
For defining the SPGRE signal, we used the following equation: 
(4.28)    
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For training the ANN, a gain insensitive input set (      
     
     




(4.29)                            
    
 
  
               
    
 
  
               
                       where k= 2, 3… 6 
These normalized signals were input to an ANN with a feed-forward multilayer perceptron 
(MLP) architecture with back propagation training algorithm. Using equation 4.27 and 4.28, for 
every T1 value ranging from 10ms to 5000ms (with 10ms intervals), SPGRE signals were 
simulated by varying the other independent parameters (T2* and M0).  Different levels of 
Gaussian noise were also added to the simulated signals to construct a set of signals with 
different SNR ranging from 2 to 30 (14 different SNR levels) and 10 to 20 (5 different SNR 
levels: 5, 10, 15, 25 and 30) for test and training sets respectively. The normalized simulated 
signals (Equation 4.28) were then input to the ANN, with their T1 value as the gold standard of 
training.  In simulations, for each SNR, the T2* and M0 in equation 4.27 were varied (as free and 







 intervals for M0 to generate different SPGRE signals for testing the ANN performance 
compared to other techniques. While all the simulated signals were used as a testing set, a subset 
of the simulated signals (n=2500) corresponding to only 5 different levels of SNRs (5, 10, 15, 
25, and 30) were used for the training set.  
To test our method, we used different data sets. One was an in house synthetic T1 map that we 
created as seen in Figure 4.2-A, which represents three different anatomical areas (WM, GM, 
and CSF). As shown in this figure, three different Gaussian distributions of T1 have been 
generated and assigned to the anatomical areas (WM, GM, and CSF) of the map using the mean 
and standard deviation of T1 values reported for these areas in the literature [82]  Figure 4.2-B 
illustrates a set of SPGRE images corresponding to a set of flip angles (2, 5, 10, 15, 20, and 25) 
constructed from the synthetic T1 map using equation 4.27.  
Also to evaluate the accuracy of the model-trained ANN against different methods, experimental 
results produced by the model trained ANN for different areas of the brain (WM, GM, and CSF) 
in six patients (30 central slices) were averaged and compared to the results of the other methods 




Figure 4.2   Figure A represents the in-house synthetic T1 map constructed from three different anatomical areas (WM, 
GM, and CSF) filled with Gaussian distribution of T1 values using mean and standard deviation of T1 values reported in 
the literature. Figure B illustrates a set of SPGRE images corresponding to a set of flip angles (2, 5, 10, 15, 20, and 25) 
constructed from the synthetic T1 map using equation 1. 
Table 4.1 shows the estimates of T1 values obtained with different methods and on human (in 
blue) and synthetic data (in red). The second row of this table shows the mean and standard 
deviation of T1 values simulated for different anatomical areas (WM, GM, CSF) of the brain 
using Gaussian distributions constructed according to the mean and standard deviation of T1 
values reported in the literature.  According to this table, mean and standard deviation of the T1 
values in different anatomical areas estimated by the model-trained ANN, NLS, GLS, and WLLS 
are strongly in agreement with the simulated values of T1 (see the 2
nd
 row of the table). This 
study also confirms that compared to the other methods (NLS, GLLS, and WNLS), the ANN is 
able to estimate the T1 value with a lower average error, for a wide range of SNRs in different 




Table 4.1. The mean and standard deviation of the T1 values for voxels falling in the White Matter (WM), Gray Matter 
(GM) and Cerebrospinal fluid (CSF) of the synthetic in-house and human data estimated using different techniques. The 
second row represents the gold standard values of T1 simulated in the synthetic data and the red values show the T1 
values estimated using different methods. The T1 values estimated by the model-trained ANN match the values of the 
synthetic data better. Also, the T1 values found in  human subjects (blue values) are more in agreement with the literature 
compared to the T1 values estimated by the other methods. 
Method White Matter Gray Matter CSF 
    
 
4.4 Estimation of Permeability Parameters Using the Pharmacokinetic Model 
In sections 4.1 through 4.3, we introduced the pharmacokinetic model and our methods for 
estimating the longitudinal relaxation rate change (∆R1) and the (pre-injection) baseline T1 map. 
These are two of the necessary components for finding the permeability. In this section, we will 
first discuss the concept of fitting the CA profiles to the Pharmacokinetic model for different 
conditions of the vessels and next, explain our method of model selection for finding the best 
fitting model for each voxel. 
4.4.1 Models of Vascular Leakiness 
In section 4.1.1, we introduced the pharmacokinetic model in the form of the Extended Tofts 
Model (Equation 4.2) and described the parameters in this model (K
trans
, kb, vp and ve).  When 
dealing with vascular permeability, three conditions can be considered for the vessels which lead 
to three nested models [66, 83]: 
(1) Impermeable vasculature where the Blood Brain Barrier is intact. 
(2) Moderate influx which is observed as leakage without efflux. 
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(3) Fast leakage which leads to bidirectional exchange. 
We have also defined fourth model which we refer to as model 0 [66]. This model represents 
voxels or areas in the image where there is no evidence of vascular filling with the CA.  In 
Figure 4.3 a schematic diagram of these four models can be seen and the leakage is explained as 
a two compartmental model: The Vascular Compartment (VC) and the Extracellular-
Extravascular compartment. In Model 0 there is no evidence of vascular filling so there is no 
exchange of the CA between the two compartments (K
trans
 = 0, kb= 0, vp= 0). In Model 1 there is 
evidence of vascular filling but no leakage to the EEC (K
trans
 = 0, kb= 0, vp≠ 0). Model 2 
indicates leakage from VC into the EEC but without reabsorption (K
trans
 ≠ 0, kb= 0, vp≠ 0). 
Finally, Model 3 shows the case where not only leakage occurs from VC to EEC, but the CA that 
has leaked into the EEC will get reabsorbed into the VC (K
trans
 ≠ 0, kb≠0, vp≠ 0) [84]. 
Based the conditions for the permeability parameters for each of these models, the Tofts model 
can be written as follows (since the application is for MR images, we will write the observation 
equation here):   
Model 0: 
(4.30)                                      
Model 1: 
(4.31)                                    
 
       
 {         } 
Model 2: 
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Figure 4.3. The four different models of vascular leakage. In Model 0 there is no evidence of vascular filling so there is no 
exchange of the CA between the two compartments (K
trans
 = 0, kb= 0, vp= 0). In Model 1 there is evidence of vascular 
filling but no leakage to the EEC (K
trans
 = 0, kb= 0, vp≠ 0). Model 2 indicates leakage from VC into the EEC but without 
reabsorption (K
trans
 ≠ 0, kb= 0, vp≠ 0). Finally, Model 3 shows the case where not only leakage occurs from VC to EEC, but 
the CA that has leaked into the EEC will get reabsorbed into the VC (K
trans
 ≠ 0, kb≠0, vp≠ 0). 
Figure 4.4 shows the CA profile sampled from three different regions in the ΔR1 maps of a 
patient with Glioblastoma Multiforme (GBM).  As seen here, the CA profile of Model 1 follows 
the trend of the AIF profile and does not indicate any leakage of the CA. But in Models 2 and 3, 
the tail of these profiles do not follow the profiles of the AIF and Model 1 tissues which is a sign 
of accumulation of CA and can be an indication of leakage of CA into the extravascular space. 
Considering these profiles for different models, and also the equations that describe each of these 
(Equations 4.30 - 4.33) the next step in our method is fitting these profiles to these models and 




Figure 4.4. (a) The AIF sampled from a major artery in the ∆R1 images of a patient with GBM. This profile represents 
the CA concentration-time curve. (b) The CA concentration-time curves sampled from the same image as (a) but from 
three regions representing Models 1, 2 and 3.  
4.4.2 Fitting the Models to the Pharmacokinetic Equation 
 Using the DR1 concentration-time maps, an Arterial Input Function (AIF) for each patient was 
picked similar to the one in Figure 4.4.a.  Because there are a number of artifacts that might be 
introduced by the movement of blood through the image slice, and by T2* signal loss, the AIF 
was adjusted by comparison to white matter in a normal area of the brain. An area of white 
matter was selected, and it was assumed that the vp of the white matter was 1% [85]. The AIF 
was scaled so that the ratio of the integrated white matter concentration-time curve to that of the 
integrated AIF was 1%. Thus, all vp‟s were measured relative to normal tissue white matter vp. 
A nonlinear least squares optimization using the Levenberg- Marquardt (LM) Algorithm[86] was 
used to fit model 3 to the experimental data, while the linear least squares method was used for 
the linear models (models 0–2). Using the AIF described in the previous paragraph, the 
concentration-time data in all voxels were fitted with the linear models 0, 1, and 2.  
4.4.3 Selecting the Best Model  
Model 1 was tested against model 0. If the F-test showed an advantage for models 1 and 2 was 
then tested against model 1. If the F-test showed an advantage for models 2 and 3 (the full 
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model) was then fitted to the data for further model comparison. To expedite the convergence 
rate of the fitting, the estimated parameters for the partial models in each step served as the initial 
values for fitting in the next step. Sum Squared Error (SSE) maps for the fitted parameters for all 
three models were calculated and used for statistical model comparison.  
4.5 AVICENNA: Software Tool for Processing DCE Images  
Using MATLAB GUI tools, we developed a software tool which we named “Avicenna Tool”. 
This software tool is used for processing DCE-MRI images using the methods explained in the 
previous sections. Figure 4.5 shows the main interface of this software. As seen in this figure, 
this software tool has several modules for performing the different processing steps, from 
creating the T1-pre and the ΔR1 maps to Model fitting and model selection. The image formats 
that this software can read are HFH (Henry Ford Hospital) and DICOM and the results are saved 
as HFH. Multi-parametric maps are created for each slice after model selection which show the 
K
trans




Figure 4.5. The main interface for “Avicenna” software tool. This tool is used for estimation of permeability parameters 









THE EXTENDED VASCULAR MODEL: COMBINING THE EFFECTS OF 
DISPERSION AND VASCULAR LEAKAGE 
In Chapter II we introduced our vascular model which was designed and implemented based on 
laws of fluid dynamics and vascular physiology. In Chapter III we showed the result of applying 
our model to DCE-CT images of the brain and there it was demonstrated that the model can 
explain dispersion in different levels of the vascular system of the brain. In section 3.4.3 the 
results of applying the model to an image with a tumor was shown and there we explained that 
since our vascular model was designed for healthy vessels (vessels with no leakage); therefore it 
is not able to explain the trend of the CA profile in DCE images that are sampled from regions 
with leaky vessels. After explaining the pharmacokinetic model and the concept of permeability 
and in chapter IV, we will proceed to introducing an extension of our vascular model that can 
explain the trend of the measured DCE signal from brain regions with leaky vessels. 
5.1 The Extended Vascular Model 
In this section, shortcomings of the vascular model and the steps for deriving the extended 
equation of the vascular model which includes parameters for leakage of the vessels will be 
discussed. 
5.1.1 Adding Permeability Parameters to the Basic Vascular Model  
The vascular model, in its current form, is able to describe dispersion of the contrast agent in 
areas of the brain where the vasculature is intact. In these areas, no leakage of the contrast agent 
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into the extravascular space is observed; therefore, the signals sampled from voxels in these 
areas mainly represent the CA profile in the intravascular space which is generally a dispersed 
form of the AIF profile in major vessels; however, when the CA leaks in the extravascular space, 
the tissue response observed in the images will follow a different trend.  
Figure 5.1(a) shows the AIF sampled from a major vessel in a series of DCE-CT images of the 
brain. Figure 5.1(b) is the CA profile sampled from normal tissue and 5.1(c) is the CA profile 
sampled from the tumor in the same image series. As seen here, in contrast to the signal from the 
normal tissue, in the case of the signal being from the tumor area, as the timepoint increases, the 
intensity of this voxel increases as well; this rise of the tail of the CA profile indicates increase of 
the CA concentration in the extravascular space. If we use the transfer function of intact vessels 
for describing the transform of the AIF to the CA profile in these two cases, we get different 
results. As seen in Figure 5.1(d) the CA profile of the normal tissue that is estimated by 
transforming the AIF using our transfer function matches the sampled signal from the tissue very 
well; however, for the tumor voxels, the best fit would be the signal seen in Figure 5.1(e). Due to 
the elevated intensity of the ending timepoints, the fitting algorithm tries to fit the two curves by 
increasing the dispersion and delay time which erroneously finds the best fit in the last layer of 
the model and with a high delay time.  
Based on this observation, to address the changes of the CA profile in areas with leaky 
vasculature and to find a more accurate estimation of the intravascular (plasma) CA 
concentration profile in these vessels, we modified our model to include leakage of the CA to the 
extravascular space. One by-product of this model is decomposing the signal to the intravascular 
and extravascular components. The result can be used for more accurate estimation of perfusion 
and permeability parameters in leaky areas which will be described later. Figure 5.2 shows a 
schematic diagram of different components in the pharmacokinetic model and their relation. 
       is the CA profile sampled at the location of one of the major arteries. The cube in this 
figure represents an imaginary voxel in the image where the tissue CA profile,        , is being 
sampled from.       is the plasma CA concentration in the vessel (or vessels) feeding the tissue 
in the voxel. It should be noted here that the profile of        and the average profile of the 
intravascular CA concentration in the voxel are not necessarily the same and theoretically there 




Figure 5.1. (a) The AIF sampled from a major vessel in the DCE-CT image series and the CA profiles sampled from (b) 
normal tissue (non-leaky vasculature) and (c) the tumor area (leaky vasculature). Using our vascular model, the transfer 
function that gave the best fit for each of the two CA profiles and the resulting TIF was found.  As seen here, for the non-
leaky vasculature case, the resulting TIF can give a good estimation of the signal sampled from the tissue (d). But in the 
case of the signal sampled from the tumor area, the best fit signal cannot follow the trend of the AIF and the best fit 





Figure 5.2. Schematic diagram showing the main components in the pharmacokinetic model and their location. AIF(t) is 
CA profile sampled at the location of one of the major arteries. The cube in this figure represents an imaginary voxel in 
the image where the tissue CA profile, Ct(t), is being sampled from.  Cp(t) is assumed to be the plasma CA concentration 
in the vessel (or vessels) feeding the tissue in the voxel. 
vascular structure in the voxel; however, considering the time resolution of the DCE signals and 
the noise level in the images, the difference will be negligible and in the following equations and 
calculations, we will use the same notation for both of them. 
According to Equation 4.1, in the pharmacokinetic model, the relationship between Ct(t) and 
Cp(t) is as follows:  
(5.1)         
     ∫                 
 
 
         
In this equation, the signal Ct(t) is composed of two main components: the second term on the 
right, vpCp(t), basically represents the time trace of the plasma CA concentration in the vessels 
that feed the tissue that Ct(t)  is being sampled from and is dependent on the fractional plasma 
volume, vp. The first term on the right,       ∫     
            
 
 
 represents the component of 
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the signal that is due to leakage of the CA to the extravascular space and is dependent on the 
forward (K
trans
) and inverse (kb) transfer rate constants.  
As we mentioned in the introduction chapter, in conventional methods of calculating the 
permeability parameters using the pharmacokinetic model, for Cp(t), the CA profile sampled 
from one of the major arteries or veins (such as the superior sagittal sinus) is usually used. 
However, this is not a correct representative of the CA profile in the tissue since it does not 
address dispersion of the CA profile in the tissue and can lead to biased estimates of the 
permeability parameters. Here we introduce a method that using our model and the 
pharmacokinetic model, separates the two components that create Ct(t). This can be used for 
estimation of both permeability and perfusion parameters. 
To address the problem of finding the intravascular CA profile in leaky vessels we added a new 
feature to the transfer function. According to the definition in Equation 3.2, the intravascular CA 
concentration profile or Tissue Input Function (TIF) can be found using the following equation: 
(5.2)                                           
Where            is the transfer function of the vessels from the major artery to a location in the 
tissue and based on Equation 3.1,            also includes a factor g, which is the system gain to 
compensate for the number of branches of vessels that can exist in the voxel being sampled. This 
equation gives a good estimate of the profile of the CA in the tissue vasculature or TIF. If in 
Equation 5.1, we replace the CA concentration profile in plasma Cp(t), with the TIF we can write 
the pharmacokinetic model as follows: 
(5.3)        
      
  
∫                  
 
 
        
And by replacing TIF from 5.2 we get the following equation: 
(5.4)                    
      
  
∫                               
 
 
                   
(5.5)                          
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(5.6)                                                           
      
  
            
(5.7)                                    [           ( 
      
  
          )]               
Where  
(5.8)                                                      ( 
      
  
           ) 
The transfer function      , which we will refer to as the Extended Vascular Model, describes 
transformation of the AIF profile to the measured tissue response at different locations of the 
vascular structure, with or without leakage of the vessels. In the case where the vessels are intact 
(non-leaky), K
trans
 will be zero and the measured signal will be basically the intravascular plasma 
concentration of the CA which can be described by convolving the AIF with           .   
Previously several approaches have been suggested for correcting the MR signal in DSC-MRI 
studies for more accurate estimation of perfusion parameters. These approaches have been 
focused on methods such as parametric modeling by fitting  a gamma-variate curve to the tissue 
response function [87], estimation of CA extravasation from the tissue residue function after AIF 
deconvolution [88]. estimation of extravasation using the voxel-wise deviation from the tissue 
response curve in a non-leaky areas [89]. Bjornerud et al. have combined this with the 
deconvolution method to directly estimate parameters of CA extravasation and perfusion from 
the tissue residue function extravasation for correction of T1- and T2*-dominant extravasation 
[90]. Our method has a similar approach however we have made no assumption about the shape 
of the residue function and also we are using the direct estimation of the transfer function 
equation based on fitting methods. Also, our transfer function based on the EVM does not 
consider the T1 and T2* competing mechanisms and in MR images and adjustments need to be 
done for applying it to DSC-MR images. 
5.1.2 Using the Extended Vascular Model for Decomposing the Tissue Response Signal 
The next step is to use the new transfer function for describing transformation of the AIF to the 
measured tissue response in voxels at different regions of the DCE image. The parameters of the 
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transfer function that can best describe this transformation can give information about the 
vascular structure and also permeability of the vessels in these voxels. We employed the fitting 
method as described in section 3.1.1, but by using the Extended Vascular Model,       , as the 
transfer function.  
To find the best fit, the transfer function equations for different levels of the vascular branching 
were implemented and for each equation, the fitting procedure was repeated. The number of 
parameters used in the fitting procedure varied from 5 to 10 parameters.  
Figure 5.3 shows the result of using the new transfer function in the fitting procedure. The two 
tissue response signals are the same as those in Figure 5.1.  In Figures 5.3(a) and 5.3(b) the bold 
lines show the best curves that are fit to the signals sampled from the normal tissue and tumor 
areas respectively. A comparison of these curves with those in 5.1(d) and 5.1.(e) show that the 
new transfer function can explain the tissue response function in both tissues with intact and 
leaky vessels.  
Another useful result of using the Extended Vascular Model in the fitting procedure is separation 
of the signals resulting from the intravascular and extravascular compartments.  After finding the 
curve that best fits to the sampled signal, using the parameters found in the fitting procedure and 
also the two main components of the Extended Vascular Model, the transfer functions describing 
the extravascular and intravascular components of the tissue response signal can be constructed 
and by convolving them with the AIF profile, each can be found as below: 
(5.9)                                                   
                       
(5.10)                                      
     
      
  
                        
Where   
     and   
     are the Intravascular and Extravascular components of the tissue 
response function respectively. Using these equations, the bold curves in 5.3(a) and 5.3(b) are 
decomposed into the Intravascular and Extravascular components as seen in 5.3(c) and 5.3(d). 
Figure 5.3(c) shows the signal from tissue with normal vasculature and therefore we do not 
expect any extravascular component in the signal. The fitting results confirm this fact and the 
extravascular component is a flat line which is the result of K
trans
 = 0 in Equation 5.10. In 
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contrast, in Figure 5.3(d) both Intravascular and Extravascular components of the tissue response 
signal exist which is the case in tissue with leaky vasculature. The important outcome of this 
method is getting an estimate of the flow component of the tissue response signal in tissues with 
leaky vasculature. This can be directly used for estimation of the perfusion parameters. This 
application will be discussed in Chapter VI. 
 
Figure 5.3.  The best fit curves to the signals sampled from (a) normal tissue and (b) the tumor area (same as the curves in 
figure 5.1) using the Extended Vascular Model (EVM) which is consisted of flow and leakage parameters. The bold curve 
shows the best fit curve in each case.  Figures (c) and (d) show the decomposed signals based on the flow and leakage 
model. The sum of the two curves in (c) and (d) would result in the bold curves in (a) and (b) respectively. As seen in (c) 
the signal is from the normal tissue and does not represent any leaky vasculature and the fitting method has found the 
best fit in K
trans 
= 0 which has resulted in the component due to vascular leak be flat and only flow paramaters have 
formed the final result of the fitting. In contrast, the decomposed bold curve in (c) can be seen here as two curves; the 
curve with a profile similar to the AIF is the flow component of the signal and the other curve is the signal from the CA 
that has leaked into the extravascular space. 
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5.2 Testing the Extended Vascular Model on DCE images 
In this section, we will test the EVM model on DCE-CT and DCE-MRI images to explore the 
performance of this model for detecting the level of the vascular branches and the permeability 
status in different regions of the brain images. 
5.2.1 Testing the EVM on DCE-CT images 
Using the Extended Vascular Model (EVM) we applied the fitting procedure explained in section 
5.1.2 to the voxels in a DCE-CT images series.  To compare the results with using the vascular 
model with no leakage (which we will refer to as the Basic Vascular Model or BVM) we 
repeated the same procedure using this model as well. For each model, the fitting procedure was 
repeated for the six different vascular branching levels. Figure 5.4 shows the residue maps of the 
fitting procedure using the BVM and EVM. One of the major observations in these images is the 
residue values of the voxels representing the tumor (which is marked with a “T”). In the residue 
maps in the top row, the tumor can be seen in all levels which indicates that the BVM cannot 
find a good fit to the data in any level of the vascular model; however, as the level index 
increases, the residue gets smaller which is due to the increased dispersion and elevated tail of 
the resulting curve as explained in figure 5.1(d); despite this, even in the residue map of L6 for 
the BVM, there is still a trace of the tumor. In contrast, in the EVM residue maps, the tumor map 
starts to appear after the L4 level and prior to that level, the residue is so low that in cannot be 
visually detected. Although the EVM has more parameters than the BVM (three more parameters 
in each level), its ability to provide a better fit cannot be necessarily attributed to higher number 
of parameters. The L1 of EVM has the same number of parameters as the L4 of the BVM and 
lower number of parameters than L5 and L6 on BVM but the fitting residue is less than these. 
These maps are shown only for visualizing the performance of these methods; to accurately 
determine the best fit, we will use model selection using the values in these residue maps. The 
results of model selection and also the permeability maps that have been created using this 
approach will be presented in section 6.2.2. 
Another observation in these two image series is the similarity of the residue maps at different 
levels for these two models in areas with intact (non-leaky) vessels. This demonstrates that the 




Figure 5.4. The residue maps of the fitting procedure using the BVM and EVM, each done with up to six branching levels. 
In the residue maps in the top row, the tumor (marked with a “T”) can be seen in all levels which indicates that the BVM 
cannot find a good fit to the data in any level of the vascular model; but this is not the case with the residues of the EVM. 
Also, the residue pattern in the non-leaky areas in both images are very similar which indicates that the permeability 
parameters of the EVM have been suppressed in these regions. 
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leakage of CA to the extravascular space will be suppressed in the fitting procedure. Also, 
observing the best fit for the tumor in the lower levels of this image set can be directly related to 
the level of the artery or arteries that are feeding the tumor. To further explore this, more tumor 
cases should be studied. The reason that the veins have residues in all levels is that our model is 
designed to explain dispersion of the CA profile only up to the capillary level and the effects of 
the veins and venules have not been accounted for. However, since the CA concentration profile 
in the veins and venules is closer to the capillaries, as the level index increases, the residual 
values decrease in the veins and the best fit for voxels from these structures happens at the sixth 
level.  
5.2.2 Applying the EVM to DCE MR Images  
To further investigate the application of the EVM in DCE imaging modalities, we used DCE 
MRI data to explore the feasibility of using this model for describing dispersion and leakage in 
these images.  
DCE MR Images of patients with cerebral tumors were acquired using the protocol described in 
section 4.1.2 and using the T1 map created using the DESPOT1 method (As described in section 
4.3.2) the temporal ΔR1 images were created by the method explained in section 4.2.1. The 
intensity of the ΔR1 images represents the CA concentration in these images.  Figure 5.5 shows 
one slice of the post-contrast DCE MR image and three ROIs sampling the CA concentration 
profiles from (a) A major artery from the circle of Willis (b) Normal White matter tissue and (c) 
the Tumor which has leaky vessels. One major difference between the temporal signals in our 
MR images and the DCE CT images is the temporal resolution of these signals. The DCE-CT 
images have a temporal resolution of 0.5 seconds and the temporal resolution of the DCE MR 
images in our study is 5.367 seconds. This means that the difference in the rise time of the 
profiles from the main inlet to the main outlet of the brain will at most be one timepoint. 
Therefore, when applying our model to this data, the major factor for fitting the curves will be 
dispersion of the CA profiles rather than delay in the rise time.  Using the BVM and the same 
procedure for finding the transfer function that gives the best fit to the profiles in (b) and (c), the 





Figure 5.5. One slice of the  post-contrast DCE MR image and the three ROIs sampling the CA concentration profiles 
from (a) A major artery from the circle of Willis (b) Normal White matter tissue and (c) the Tumor which has leaky 
vessels. Figures (d) and (e) show the best fit curves using the transfer function found using the BVM. As seen here, the 
curve fit to the normal tissue follows the trend very well but even in the best fit curve, this model is not able to match the 




Figure 5.6 (a) The best fit curve to the signal sampled from the normal tissue and (b) The tumor area. (c) Shows the flow 
and leakage components of the bold curve in a. As seen here , the leakage component is a flat line indicating no leakage 
(d) The two components of the bold signal in b shows that in addition to the flow component, there also exists a 
component indicating leakage. 
 As seen in this figure, in the case where the profile is sampled from the normal tissue (no leaky 
vessels), the BVM can find a good fit to the tissue response that follows the trend of the profile 
very well; however, when the data is from the tumor area, even the best fit is far from the 
sampled curve.  
We repeated the fitting procedure as the DCE-CT case, using the EVM. Figure 5.6 shows the 
best fit curves to the CA profiles in Figure 5.5(b) and 5.5(c). We applied this fitting procedure to 
all the voxels in a set of DCE-MR Images using both BVM and EVM. The residual value maps 
of this procedure are seen in Figure 5.7. Similar to the DCE-CT case, the EVM is able to find a 
good fit for the CA profile in the tumor area which leads to the fitting residual values to be much 
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lower for the first two branching levels of this model. Considering the location and the size of the 
tumor in the brain, it is likely that it is being fed by one of the major arteries such as the ACA or 
an immediate branch of it which leads the CA profile have a good fit in the lower branching 
levels. The BVM is not able to find a good fit to the CA profile in the tumor area in any of the 
branching levels which is what is expected. 
As in the DCE-CT case, the two models show similar residual patterns in areas with non-leaky 
vessels which indicates that when the permeability parameters (or more specifically K
trans
) are 






Figure 5.7. Maps of the fitting residual values using the EVM and BVM in a set of DCE MR Images. The residual values 
in the tumor area are much lower for the EVM which means that this model can explain the trend of the CA profile in the 
leaky vasculature areas much better than the BVM. Finding the best fit in the lower levels can be due to the tumor being 










RESULTS OF USING DIFFERENT AIF PROFILES AND THE 
CORRECTED TIF PROFILE 
In Chapter IV, we introduced the methods and software that we have developed for estimation of 
permeability parameters in DCE-T1 and Dynamic Dual-Gradient-Echo images. In this chapter 
we will discuss the effects of selecting different AIFs in the Pharmacokinetic model and show 
how it changes the estimated values of the permeability parameters. Initially in section 6.1we 
will demonstrate the effects of using different AIFs on the estimated permeability parameters and 
also the difference in the estimated parameters when using the DCE-T1 Signal Intensity instead 
of the ΔR1 signal. Finally we will compare the permeability and perfusion parameters estimated 
by using the conventional AIF and the TIF found by the EVM using both DCE-MRI and DCE-
CT data in tumor patients as well as in simulated DCE-MR signals.  
6.1 Effects of Using Different AIFs on the Estimated Permeability Parameters 
In this section, the results of a two comparison studies will be presented that show the effects of 
using different AIFs for calculation of permeability parameters. The calculations in this section 






6.1.1 Using Standard Radiological AIF vs. and Manually Selected AIF 
The purpose of this portion of the study was to compare the results of using a Standard 
Radiological Arterial Input Function (SRAIF) vs. the Manually Selected Arterial Input Function 
(MSAIF) in Dynamic Contrast Enhanced (DCE)-MR image analysis to compare the estimated 
permeability parameters such as extracellular-extravascular space volume (ve), plasma volume 
(vp) and forward vascular transfer constant (K
trans
). The SRAIF is the result of a previous study 
[91, 92] where 13 Wistar rats were injected with radiolabeled Gd-DTPA and CA concentration 
was sampled at the Carotid Artery of rats at a relatively high temporal resolution by counting β 
emissions in a well counter at different time points . The measured AIF profiles were then 
calibrated to the blood relaxivity and averaged to construct the SRAIF. This SRAIF is considered 
to be a standard curve representing the AIF measured in the carotid artery for use in the 
Pharmacokinetic model for rats. Figure 6.1 shows the SRAIF and one MSAIF used in this study.  
 
Figure 6.1. The normalized and rise-time corrected SRAIF (red) and MSAIF (blue) from of one of the rats after 
intravenous bolus injection of GD-DTPA 
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In  the current study, Nine Fisher 344 female rats were inoculated intra-cerebrally with 9L 
Gliosarcoma cells that were cultured in Dulbecco‟s modified eagle‟s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS).  Cells were harvested and re-suspended and 5 
µl of the cell suspension with a concentration of 8×10
7
/ml was implanted into the rat brain.  
Imaging was done using Gd-DTPA on the 14
th
 day after inoculation.  
For imaging, the animals were scanned on a GE-3T clinical system (Signa Excite, GE health) 
using a 50mm(diameter)×108mm RF rung length small animal imaging coil (Litzcage small 
animal imaging system, Doty Scientific Inc., Columbia, SC).  One set of T1-pre followed by a 
set of DCE-T1 weighted images and a set of T1-post images were acquired in each experiment. 
For creating the resting (pre-contrast) T1 maps, multiple flip angle (2°,  5°, 10°, 15°, 20°  and 
25°) fast 3D Spoiled Gradient Echo (3D SPGRE) images were obtained using the following MR 
specifications: TR/TE=500/12 ms, 256×256 matrix, 13 slices, 1 mm thick, 40×30 mm FOV, 
NEX=4. A series of 3D SPGRE (flip angle = 30°) image packs were acquired every 11.7 sec for 
a total scan time of 15 minutes.  Gd-DTPA was administered as a bolus through the tail vein of 
animal over 10 seconds at 0.2 ml/kg (0.1 mmol/kg). We used our Model Selection approach [66] 
(as described in section 4.4.3) to estimate permeability parameters from these DCE-MR 
experiments as explained in chapter IV using Tofts extended model and its reduced forms [65].  
Using the methods explained in chapter IV [66], resting T1 maps along with the baseline (before 
CA administration) of the dynamic signal were used to calculate the relaxivity change (∆R1). F-
Statistic was used to select the best model for each voxel. Model 3 was the focus of this study 
due to the fact that it allows us to measure three permeability parameters (vp, ve, and K
trans
). All 
analyses were done using SRAIF and MSAIF. The MSAIFs were selected by an expert 
radiologist for each animal. For each animal and for each CA, two AIF profiles were used for the 
analysis: Both AIFs were calibrated to blood relaxivity and normalized to the CA concentration 
of the white matter. Also, the SRAIF profile was shifted in time so that its rising point matched 
that of the AIF in the same animal (Figure 6.1).  




 and ve that have been measured for 
the whole lesion (only Model 3 areas) in all nine animals. For assessment of the significance of 
the difference of the mean values of each of the parameters between the two groups, paired T-
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test was performed along with calculation of the Intra-class Correlation (ICC) between the 
results from using the two AIFs.  
These results show high correlation between the K
trans
 values calculated using the two AIF 
profiles (ICC = 0.94) which shows perfect agreement; Also, the mean values of ve and vp  have a 
lower correlation when they are calculated for the two different AIFs (for ve , ICC = 0.42 and for 
vp, ICC = 0.56).  
The results show less variation in the estimated values of K
trans
, compared to ve, vp. Thus using 
MSAIF compared to SRAIF would not significantly affect K
trans
 due to the fact that this 
parameter is relevant to the trend of the time trace of CA concentration in both AIFs. However, 
ve and vp are more susceptible to the AIF profile change. These results show the importance, 
sensitivity and biasing level of each estimated permeability parameter against different AIF 
profiles. Further investigation using Quantitative Auto-Radiography (QAR) and histology 
measurements of the vascular physiology parameters would allow us to investigate the accuracy 
and biasing effect of each AIF on the estimated parameters. 
Table 6.1. Mean and standard deviation of the permeability parameters, estimated using the SRAIF and MSAIF. The P-
value of the Paired T-test and the Inter-Class-Correlation were calculated between the estimated values of the 
permeability parameters calculated using the two AIFs. 
 GD-DTPA 





) 0.046±0.011 0.048±0.010 0.3008/0.9382 
ve (%×100) 0.236± .056 0.202± .031 0.1289/0.4203 
vp(%×100) 0.016±0.004 0.016± .006 0.9102/0.5620 
 
6.1.2 Comparison of Results Using DCE T1 Signal Intensity vs. ΔR1 
In section 4.2.3, we explained that recently there have been studies that suggest using the 
normalized DCE T1 signal instead of ΔR1in permeability studies. However, there has been no 
report of comparing the results obtained using these two methods.  Here we present the results of 
a comparison study that we did to investigate the difference of the estimated parameters. 
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For this study DCE-T1 imaging was conducted in 10 treatment naive patients with GBM. All 
studies were performed in a 3T GE Excite HD MR system using a standard eight-channel 
phased-array RF coil and receiver.  Before CA administration, T1 mapping was performed using 
a 3D SPGRE sequence with Variable Flip Angle (VFA). Sequence parameters were as follows: 
TE/TR ~ 0.84/5.8 ms, flip angles, θi, of 2, 5, 10, 15, 20, and 25º, matrix of 256 ×128, FOV of 
240 mm, 16 slices, 5 mm slices, no gap. The maps of T1 were used to establish baseline pre-
contrast values for the dynamic SPGRE procedure that followed. The 3D SPGRE DCE-T1 
sequence was then begun (70 image sets ~5.9s per image set, θ=20 and other parameters as 
above). About 20s after starting, a dose of Magnevist (0.1 mmol/kg) was injected (IV) at a rate of 
4 mL/s. ΔR1 was calculated analytically for each voxel using the nominal value of the tip angle, 
θ , the estimated pre-contrast value of T1, and the ratio of the post-contrast to baseline pre-
contrast MRI signal. For calculation of ΔR1, we used the equation in section 4.2.2 a measure of 
the CA concentration-time curve. Using a manually chosen Arterial Input Function (normalized 
to white matter), the SI and ΔR1 data in all voxels were fitted with the linear models 0, 1, 2 and 
non-linear model 3 as explained in section 4.4.1. Sum Squared Error (SSE) maps for the fitted 
parameters in all three models were calculated and used for statistical model comparison. Three 
F-test maps were constructed using the SEE maps that served for model comparison. Model 0 vs. 
1, Model 1 vs. 2 and Model 2 vs. 3 were tested with the F-test criteria and a final regional map, 
and three maps of permeability parameters were constructed accordingly.  
Table 6.2 shows the results of estimating the permeability parameters using these two signals. As 
seen here, compared to the ΔR1 technique, the SI technique underestimated the plasma volumes 
(vp) for different regions (32% in normal but enhancing core, 26% in white matter, 17% in gray 
matter, and 32% in Model 2 and 24% Model 3 regions). In contrast to the ΔR1 technique, the SI 
technique also underestimated K
trans
 around 22% and 28% in regions `associated with Model 2 
and 3 respectively.  
The SI technique also overestimated kb around 23% in the model 3 region compared to ΔR1. The 
mean calculated interstitial space ve = K
trans
/kb (only in Model 3) was underestimated about 38% 
in the SI technique compared to the ΔR1 technique. In Model 3 regions, excellent curve fits were 
obtained in both of the techniques to explain the variation of the ΔR1 and SI data (mean R2 = 
0.99 and 0.97 for ΔR1 and SI techniques respectively). Results imply that estimation of 
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pharmacokinetic parameters using the SI technique results in values that are significantly 
different with those estimated using the ΔR1, considering the fact that the ΔR1is a better 
indicator of the CA concentration, it is expected that the permeability parameters estimated using 
this signal would be closer to the actual value; however, validation of these parameters requires 
other methods such at histology or autoradiography. 
Table 6.2. Summary of estimates of vascular parameters in 10 patients. These results show the signifinant difference 
between the estimated permeability parameters using the Signal Intensity and the ∆R1. 
 Model 1 (core) Model 2 Model 3 
Permeability Parameters           vp        vp                         K
trans
        vp                    K
trans
                      ve                        R
2 
Mean ± SD (∆R1) 0.0213 ± 0.0195 0.028 ± 0.025    0.0019 ± 0.0019 0.037 ± 0.019     0.019±0.010       0.076 ± 0.048       0.9912 
Mean ± SD (SI) 0.0144 ± 0.0163 0.019 ± 0.021    0.0014 ± 0.0027 0.028 ± 0.024   0.013 ± 0.016       0.045 ± 0.034       0.9724 
 
6.2 Results of Using the Model Corrected AIF  
In the previous section, we demonstrated that using different AIFs can lead to biased estimates of 
the values of permeability parameters, especially ve and vp.   In the following sections, the results 
of using the TIF using our vascular model for perfusion and permeability studies will be 
explored and the results will be compared to the those obtained using conventional methods. In 
the next session, we will first briefly review the methods for estimating the main perfusion 
parameters and next, we will show the application of the EVM for less biased estimation of these 
parameters. 
6.2.1 Estimation of Perfusion Parameters in DCE-CT Imaging Using the EVM 
In perfusion analysis, Cerebral Blood Volume (CBV), Cerebral Blood Flow (CBF) and Mean 
Transit Time (MTT) are estimated based on Fick‟s General Principle [93] : 




Where    ,       and       are defined as the tissue, arterial and venous CA concentrations 
and F is the cerebral blood flow.      is also referred to as the Tissue Concentration or Tissue 
Residue Function. The units for     ,      and       are (mmol. mL
-1








One practical but approximate method for estimating the blood flow using this equation is to do 
measurements of      and       within the mean transit time of the brain (4.5-6.5 seconds) 
[93]. This way, the venous outflow will be assumed to be zero and the equation can be written 
as: 




The estimated Flow using this method is very inaccurate and the results do not tend to be 
consistent. An alternative method for estimating the CBF is deconvolution analysis. This method 
does not make any assumptions about the venous outflow being non-existent. The base of the 
deconvolution method is the following equation: 
(6.3)                    
This equation describes a relationship between       and      through      which is called the 
impulse residue function. If          is a delta function, meaning that the unit mass of CA is 
totally injected at time t=0, the tissue response function,     , is assumed to have the form as 
seen in Figure 6.2 which is the general form of      . The initial plateau of      is considered to 
be the minimum transit time from the arterial inlet to the venous outlet of the brain vascular 
network.  
In perfusion studies,      and       are measured in the tissue voxels and a major artery in the 
DCE image and the deconvolution between these two will give an estimate of           .  
Using       , by definition, CBV, CBF and MTT are calculated as follows [93]: 
(6.4)                               
(6.5)                                
(6.6)     
   
   
 
                        
                          
 
Many methods have been proposed for deconvolution and are being currently used in perfusion 
analysis. New approaches have led to more stable deconvolution methods in presence of noise; 
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however, this is still an open problem.  Also, one critical note about the tissue impulse function is 
that equation 6.3 is using the assumption that the CA is limited to the intravascular space and 
there is no leakage into the extravascular space. In the case where the BBB is compromised, area 
under the      will be the summation of intravascular and extravascular CA and therefore, CBV 
will be overestimated. In such cases, calculation of the CBV will not be as straightforward as 
calculating the area under the curve. This makes perfusion analysis in leaky vasculature a more 
complicated issue. One solution is extrapolating the training slope of       using a mono-
exponential function. 
 
Figure 6.2. Schematic plot of the impulse residue function, R(t) 
Here, we introduce another approach for perfusion analysis using our vascular model. The BVM 
or the intravascular component of the EVM both provide estimates of the flow transfer function 
from the main artery to each voxel in the image. A close look at the equations 5.2 and 6.3 show 
that        is basically the transfer function that we have defined using our vascular models: 
(6.7)                   
85 
 
Therefore by estimating our model based transfer function, R(t) can be directly found, without 
using deconvolution analysis. The advantage of our method is that by using the EVM, we can 
find an estimate of the intravascular component of the tissue response (or in other words the 
impulse residue) function in leaky areas and directly estimate the perfusion parameters using the 
transfer function of this intravascular component. 
 
Figure 6.3. The MTT maps for two slices calculated using the clinical software, the Basic Vascular Model (BVM) and the 
Extended Vascular Model (EVM). As seen in the first row, the MTT for the tumor area (marked with T) is estimated 
around 15 seconds by the clinical software. When using the BVM, the MTT values are also estimated to be in the same 
range as the clinical software, however, this overestimation using the BVM is due to the inability of this model to separate 
the tissue response due to intravascular and extra vascular CA concentrations. The MTT values in the tumor area are 
around 8 seconds when the EVM is used. 
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Using this approach, and the method described in the previous chapters, by selecting a reference 
AIF around the location of the circle of Willis in a DCE-CT image series of the brain of a patient 
with a cerebral tumor, we found the transfer function at every voxel in the brain and by using the 
equations above, calculated the MTT in the image. Figure 6.3 shows two slices of this image, 
along with the results of analyzing the same images using the clinical software. As seen in this 
figure, in the first row, the MTT for the tumor area is estimated to be around 15 seconds by the 
clinical software. When using the BVM, the MTT values are also estimated to be in the same 
range as the clinical software, however, this overestimation using the BVM is due to the inability 
of this model to separate the tissue response resulting from intravascular and extravascular CA 
concentrations. When the MTT values are calculated using the TIF estimated by the EVM, in the 
tumor area these values are around 8 seconds. 
6.2.2 Estimation of Permeability Parameters in DCE-MR Imaging Using the EVM 
In this section, we demonstrate the results of using the EVM for estimation of the permeability 
parameters and compare them to the case where a global AIF is used for solving the Tofts 
Pharmacokinetic equation. The method and software for estimating the permeability parameters 
using the global AIF has been explained in detail in sections 4.4 and 4.5. In section 5.2.1, we 
described the method for using the EVM to estimate the transfer function that converts the AIF 
to the tissue response function in each voxel. Here, we use the results of that section to show the 
permeability parameter maps in these images. 
After estimation of the EVM based transfer function for every voxel in the image, in addition to 
the parameters describing the vascular structure connecting the major artery and the vessels 
passing through that voxel, the permeability parameters are also directly estimated as a 
byproduct of the method. Depending on the model of the leakiness that is being considered, at 
each branching level, the transfer function can have one (vp), two (vp, K
trans
) or three (vp, K
trans
, 
Kb) parameters to represent models 1, 2 or 3.  Therefore the fitting procedure was repeated 18 
times to take into account all combinations of six levels of vascular branching and vascular 
leakiness.  After estimating all 18 transfer functions based on the fitting procedure, the AIC was 
calculated using the resulting RSS and the combined model with the lowest AIC was selected as 
the best fitted model. Figures 6.4-a, c and e show the three permeability maps (vp, K
trans
, Kb) that 
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were estimated by solving the pharmacokinetic model using the global AIF for the DCE-MR 
series of the slice shown in 6.4-g. Figures 6.4-b, d and f show the same maps that were estimated 
using the TIF found by the EVM. As seen here, in the vp map, in the non-leaky areas, the values 
found by the two methods are very close; however, the vp values in figure 6.4-a show lower 
values in the tumor area compared to figure 6.4-b.  This can be interpreted as underestimation of 
the plasma volume fraction in leaky areas when the global AIF is used. The simulation study in 
the next section confirms this. Comparison of the K
trans
 and Kb maps show that compared to the 
case when the EVM is used, the values of K
trans
 and Kb are under and overestimated respectively. 
Assessment of the accuracy of either method should be investigated using methods such as 
histology or autoradiography, however the results of the simulation study reported in the nest 





Figure 6.4. (a, c and e) the three permeability maps (vp, K
trans
, Kb) estimated by solving the pharmacokinetic model using 
the global AIF for the DCE-MR series of the slice shown in (g). (b, d and f) permeability maps estimated using the TIF 
found by the EVM. (h) Model selection map estimated using the RSS of the fitting procedure and finding the minimum 
AIC. 
6.3 Comparison of Performance of the EVM vs. Using the Global AIF: A Simulation 
Study 
In section 4.4, we described the conventional method that is used for solving the Tofts 
pharmacokinetic model to estimate the permeability parameters. One of our main goals for 
developing the vascular model (especially as the extended form) was more accurate estimation of 
the permeability parameters. We had hypothesized that by estimating the local AIF or in other 
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words the TIF and using that for solving the pharmacokinetic model (instead of using the global 
AIF), we will be able to find more accurate estimates of these parameters. However, even after 
applying this method to in vivo data, still validation of the method and estimated parameters will 
still be an issue. In animal models, methods such as histology or autoradiography can be used for 
measurement of vp, K
trans
 or ve, however, for human data, validation in this form would be 
impossible. Therefore, to compare the performance of these two methods for estimation of the 
permeability parameters, we conducted a simulation study using our model to compare the value 
of the estimated parameters using these two methods.  
In the first step, using a sampled AIF from the circle of Willis in the ΔR1 image series estimated 
from the DCE MRI series of a human subject, we estimated curves of the dispersed AIF at 
different levels of the vascular system using our vascular model. Figure 6.5 shows these curves. 
The time resolution of these curves is 5.8 seconds therefore considering the fact that the transit 
time of blood in the brain is about 5 seconds the temporal shift in the rise time of these signals 
will be at most one timepoint cannot be visualized with the time resolution of these signals. The 
peaks of these curves have been scaled to the same value for better comparison of the curves. 
For our simulation, we separately tested the two methods for each of the three categories of the 
Pharmacokinetic model as described in section 4.4.2.  
For model I, which is considered to be the model with no vascular leakage, the only parameter 
that is included is the fractional plasma volume, vp. Using different values of vp, several tissue 
response signals were simulated for different levels of the vascular branching structure. Then 
using the PKM with global AIF and also the EVM, the value of vp was estimated in these curves. 
Figure 6.6 and Figure 6.7 show the best fit curves in the case of vp = 0.01, that is estimated using 
the two methods. As seen in Figure 6.6, in the case of using the global AIF, since the TIF is not 
corrected for dispersion, as the level of the vascular branching increases the mismatch between 
the profiles increases as well. In contrast, as Figure 6.7 shows, for all levels of the vascular 





Figure 6.5. The AIF sampled from  the circle of Willis in the ΔR1 image series estimated from the DCE MRI series (bold 
curve) and the curves of the dispersed AIF at different levels of the vascular system found using our vascular model. The 
time resolution of these curves is 5.8 seconds therefore the temporal shift in the rise time of these signals cannot be 





Figure 6.6. The best fit of AIF (bold) to the simulated tissue response curves as seen in Figure 6.5 (thin) for solving the 
first configuration of the pharmacokinetic model. The solution to this equation is vp, the fractional plasma volume. As 
seen in these curves, since the AIF is not corrected for dispersion, as the level of the vascular banching increases, the 




Figure 6.7. The best curves (bold) fit to the same simulated TIF signals (thin) as in Figure 6.6, using the EVM and the first 
configuration of the pharmacokinetic model . In all levels of the vascular model, the fit curve matches the profile very 





Figure 6.8. (a) The vp values estimated by solving the PKM equation using the global AIF and the EVM as shown in 
Figure 6.6 and Figure 6.7. As explained there,  when the EVM is used, the estimated vaue of vp much closer to the nominal 
value compared to using the AIF which leads to underestimation of vp. (b)-(d) show the estimated values of vp for 
simulating a fractional plasma volume of 0.02, 0.04 and 0.05 
In Figure 6.8 the results of estimating vp using the two methods is presented. The signals were 
simulated for four values of vp (0.01, 0.02, 0.04 and 0.05). The observation in all these graphs is 
that when the global AIF is used, starting from the first level of vascular branching, the value of  
vp gets underestimated and the gap between the estimated value and the nominal value increases 
as the tissue response signal gets more dispersed. But the values estimated by the EVM remain 
very close to the nominal value at all levels of the vascular branching.  
In the next step, the same procedure was repeated but this time, when simulating the tissue 
response signals, Model II was considered. When creating these signals, the forward transfer rate 
constant (K
trans
) was added to the equation to model leakage of the vessels. Next, using the global 
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AIF and the EVM corrected AIF, the pharmacokinetic model was employed to estimate the 
values of K
trans
 and vp in these simulated tissue response signals. 
In Figure 6.9 and Figure 6.10 the curves that are fit to the tissue response signals simulated with 
vp = 0.01 and K
trans
 = 0.001 (1/min) are presented. As seen in Figure 5.9, when the global AIF is 
used, the best fit curve does not follow the trend of the simulated TIF in the higher vascular 
levels. But in Figure 6.10 when the EVM corrected AIF is used, the resulting curves match the 
simulated signal in all levels. This figure shows the decomposed intravascular and extravascular 
components of the signal which are both used for estimating the vp and the K
trans
 values. 
In Figure 6.11, curves are plotted which  show the estimated values of K
trans
 and vp, calculated 
using the global AIF and the TIF estimated by the EVM, assuming that they are sampled from 
six different levels of the vascular tree. Figure 6.11 (a) and (b) show the case where vp = 0.01 and 
K
trans
 = 0.001 (1/min) and Figure 6.11 (c) and (d) represent vp=0.01 and K
trans
 = 0.005 (1/min). As 
seen here, in both configurations, the K
trans
 values found using the global AIF are overestimated 
at all branching levels and as the vascular levels increase, this value increases as well. In the case 
of K
trans
 = 0.001, the over estimation can be as much as 9 times the nominal value and in the case 
of K
trans
 = 0.005, this is about 3 times the nominal value. But for the case of using the EVM, the 
value of K
trans
 is at most 1.6 times higher than the nominal value. In the case of the estimated vp, 
similar to the case of the first configuration of the Pharmacokinetic model, when using the global 
AIF, the fractional plasma volume is underestimated starting from the first level and is 
underestimated by about half the nominal value when it gets to the last level. In the case of using 




Figure 6.9. The best curves (bold) fit to the simulated tissue response signals (thin) having vascular leakage with the 
second configuration of the  PKM. The two paramaters in this configuration are vp and K
trans
. The TIF used here is the 
AIF and as seen here, the best fit curve does not follow the trend of the simulated TIF in the higher vascular levels. The 
values af vp and K
trans





Figure 6.10. The curves fit to the simluated tissue response signals using the EVM. The bold curves show the fit curve and 
the thin lines represent the extravascular (lower thin line) and intra vascular (upper thin line) components. The 
inrtravascular and extravascular components are used for estimating the vp and the K
trans




Figure 6.11. Estimated values of K
trans
 and vp calculated by solving the Pharmacokinetic model using the global AIF and 
the TIF estimated by the Extended Vascular Model for simulated signals. These signals were created assuming that they 
are sampled from six different levels of the vascular tree. Also, leakage was added to the vessels based on the second 
configuration of the pharmacokinetic model where only K
trans
 and vp exist in the equation. Figures (a) and (b) show the 
case where vp = 0.01 and K
trans
 = 0.001 (1/min) and (c) and (d) represent vp=0.01 and K
trans
 = 0.005 (1/min). As seen here, 
in both configurations, the K
trans
 values found using the global AIF are overestimated at all branching levels and as the 
vascular levels increase, this value increases as well. In the case of K
trans 
= 0.001, the over estimation is about 9 X the 
nominal value and in the case of K
trans
 = 0.005, this is about 3X. In contrast, for the case of using the EVM, the value of 
K
trans
 is at most 1.6X higher than the nominal value. In the case of vp, similar to the case of the first configuration of the 
Pharmacokinetic model, in the case of using the global AIF, the fractional plasma volume is underestimated from the first 
level and is underestimated by about half the nominal value. In the case of using the EVM, the estimated value of vp is 
almost always accurate. 
In the last step, the tissue response signal was simulated using model III of the Pharmacokinetic 
model in which a third parameter, Kb was added. Similar to the other two models, we estimated 
these three parameters using our two methods and compared the results. Figure 6.12 and Figure 
6.13 show the fitting results at different branching levels using the two methods.  The values of 
vp, K
trans
 and Kb used in the simulation for creating the tissue response curve are 0.01, 0.005 
(1/min) and 0.5 (1/min) respectively.  
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One observation in Figure 6.12 is that even though the global AIF is used, the best fit curve 
follows the trend of the simulated TIF better than the case of the second configuration of the 
PKM (as seen in Figure 5). One reason for the better fit is the extra parameter (Kb) added to the 
equation. The presence of Kb will compensate for dispersion of the AIF; however, the fitting 
process will lead to overestimation of Kb. Similar to the previous cases, in the case of the EVM 
corrected AIF (Figure 9) the estimated curve fits the simulated signal very well.  
Figure 6.14 shows the graphs comparing the estimated values of K
trans
, Kb and vp using the two 
AIFs for two sets of simulated signals. These signals are created using K
trans
 = 0.005 and vp = 
0.01 and two values for Kb (0.2 and 0.5).  As seen in both signal sets, the value of vp estimated 
by EVM is almost the same as the nominal value. Also the values of K
trans
 and Kb are estimated 
close to the nominal value and even though at some of the branching levels they deviate from 
this value,  but it is much less than the estimates when using the global AIF.  In this case, the 
value of K
trans
 can be overestimated as much as 7 times and Kb and high as 4 times the nominal 
value. 
Although the full range of the parameters was not considered here, the results show that when 
using the EVM estimated TIF, the estimated parameters are less biased compared to using the 
global AIF. Although in this simulation study, when using the EVM, the same transfer function 
is used for creating the tissue response signals and for transforming the AIF; however, the 
accuracy of the results show the reliability of this model for estimating the permeability 
parameters by decomposing the tissue response signal to the intravascular and extravascular 
components which is the main advantage compared to using the global AIF. Comparing these 
simulation results with the results obtained from processing the DCE-MRI data discussed in 
section 6.2.2 confirms the results found when using real data. Compared to the case when the 
TIF is corrected, the permeability parameters estimated in the tumor area by using the global 




Figure 6.12. The best curves (bold) fit to the simulated tissue response signals (thin) having vascular leakage with the 
third configuration of the  PKM. The three paramaters in this configuration are vp,  K
trans
 and Kb. The TIF used here is 
the AIF and as seen here, the best fit curve does follows the trend of the simulated TIF better than the case of the second 
configuration of the PKM (as seen in Figure 5). The reason that the better fitting occurs is the extra parameter (Kb) added 
to the equation. This will compensate for the dispersion of the AIF; however, it will lead to overestimation of Kb. In these 
TIFs, the values af vp,  K
trans




Figure 6.13. The curves fit to the simluated tissue response signals using the EVM with three permeability parameters. 
The bold curves show the fit curve and the thin lines represent the extravascular (upper thin line) and intra vascular 
(lower thin line) components. The inrtravascular and extravascular components are used for estimating the vp, K
trans
 and 





Figure 6.14. Estimated values of vp, K
trans
 and Kb, using the PKM and global AIF vs.  the EVM. The curves on the left (a, 
d, f) a represent the case where Kb = 0.2 and the curves on the right represent  Kb = 0.5. In both cases K
trans
 = 0.005 and vp 
= 0.01. As seen in both cases, the value of vp estimated by EVM is almost the same as the nominal value. The values of 
K
trans
 and Kb are estimated close to the nominal value and even though at some of the branching levels they deviate from 
that value but it is much less than the case of the estimates done using the AIF.  In this case, the value of K
trans
 can be 









In this dissertation, a novel vascular model is introduced that we have developed based on the 
laws of fluid dynamics and vascular morphology for formulating dispersion and delay of the AIF 
at different branching levels of the brain vascular system and for finding the AIF at the tissue 
level (TIF).  To test our model and methods, we carried out a simulation study and also studied 
the application of our method in DCE-CT and DCE-MR images of the human brain. Our model 
can analytically explain dispersion of the contrast agent profile at different levels of the vascular 
tree in the brain without any assumptions about the profile of the contrast agent. Simulation 
results showed high accuracy in finding the level of the CA profile in the vascular tree and the 
contribution of CA profiles at different levels of the vascular tree. Also, we extended our 
vascular model to address effects of leakage of the CA to the extravascular space. The Extended 
Vascular Model describes the measured tissue response function in DCE images based on 
dispersion of the AIF in the vascular structure as well as leakage of the CA to the extravascular 
space, using systems analysis methods. We used the extended vascular model to decompose the 
tissue response function measured by the DCE imaging into its intravascular and extravascular 
components. This exciting aspect of our model has opened the door to many possibilities for less 
biased estimation of perfusion and permeability parameters using DCE imaging.  In another part 
of our research, we also studied the results of using different AIFs for calculating the 
permeability parameters of vasculature and measured the bias that is added to the estimated 
parameters in each case. 
The scientific contributions of this research can be summarized as follows: 
- Deriving an equation for the transfer function of a single vessel with laminar flow 
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- Design and implementation of a three dimensional model of the brain vascular structure 
for simulating blood flow and dispersion based on the single vessel transfer function 
- Developing a model (transfer function) for decomposing the tissue response signal to the 
intravascular and extravascular components of the signal in areas with leakage of the 
vessels based on a model of the brain vascular structure. 
- More accurate estimation of permeability and perfusion parameters using the 
decomposed tissue response signal 
- Assessment of performance of different methods for estimating T1 maps using Variable 
Flip Angle SPGRE images and introducing a novel adaptive system for T1 map 
estimation 
- Using model selection for estimation of permeability parameters using the different forms 
of Tofts extended pharmacokinetic model  
- Assessment of the variations in estimating the permeability parameters based on using 
different AIFs  
- Assessment of the variations in estimating the permeability parameters based on using 
∆R1 or the Intensity of DCE-MR signals 
- Design and Development of a software tool for processing DCE-MR images for 
estimation of permeability parameters for human and animal data. This software in 
currently being used and evaluated in four centers. 
- Design and Development of a new software tool for processing DCE-MR and DCE-CT 
images for estimation of permeability and perfusion parameters for human data. This 
software is based on the new model and currently being internally evaluated. 
- Providing a tool to potentially reduce the total scan time in permeability studies using the 
extended model for analyzing the data.  
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Our novel semi-empirical model of the brain vascular system was designed and implemented 
based on laws of fluid dynamics and morphology of the vascular structure in the brain. Other 
methods have been suggested for modeling dispersion in the vascular structures but they have 
modeled dispersion based on only delay of parallel branches [16] or in the case of extensive 
modeling of flow in the vascular structure in the whole body, only flow in major vessels has been 
addressed [21, 22]. In the work by Calamante et al. [17] the effects of delay and dispersion have 
both been addressed but the transfer function used is an estimate. In another study Gallichan and  
Jezzard [31] introduced an approach similar to ours  which used the dynamics of laminar and 
pulsatile flow for finding the dispersion of the bolus and obtained an equation for describing it; 
however, this equation only described the dispersion of a box-car shaped bolus and also it did not 
address the effects of branching of the vessels on the dispersion of the bolus profile. The 
advantage of our model is that we did not make any assumptions about the profile of the contrast 
agent (such as it being a gamma variate, Gaussian function or square etc.) and we used a transfer 
function that we estimated based on laws of fluid dynamics in the vessels and have also used 
facts of vascular morphology in developing it which makes it unique. This novel model can 
analytically explain dispersion of the contrast agent profile at different levels of the vascular tree 
in the brain and most importantly in the capillary bed.  The vascular model in its current form, 
does not include all aspects of the laws of fluid dynamics and vascular physiology such as 
turbulence at the bifurcation points in the vessels; but even though it is not accurate in that sense, 
considering the data modalities and also the time resolution of our dynamic experiments, it can 
explain dispersion in the brain vasculature very well. Also, it should be noted that the model that 
we have used in this study mainly describes arteries, arterioles and capillaries and in order to 
describe the veins and venules, more parameters should be added to the model to address the 
dispersion of the CA profile in the veins more accurately. However, considering the fact that the 
total volume fraction of capillaries, veins and venules consist at most 3% of the total brain 
volume [94], the likelihood of selecting a voxel representing a vein is very low. For this reason 
and also to avoid the unnecessary increase of the complexity of our model at this point, we did 
not include that in our analysis.   In the first stage of developing our model, we assumed that the 
vessels follow the morphology and characteristics of healthy vessels 
To test the performance of this model, CA profiles were simulated at different levels of the 
vascular tree.  A combination of simplex (for fitting) and AIC (for model selection) methods 
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were used to find the level of the simulated CA profiles; the results showed high accuracy in 
finding the level of the CA profile in the vascular tree, in presence of noise; even with up to 18% 
noise, the correct level was detected with almost 100% accuracy. Also these simulations showed 
the ability of our method to separate original signals in a composite signal even when it was 
contaminated with almost 50% noise. The good performance of this method in presence of noise 
shows its robustness for finding the vascular branching level of signals in non-simulated data.  
To test our model with in vivo data, the same method was applied to DCE-CT images of the 
human brain.  For every voxel in these images, the transfer function of the vascular structure was 
found and using the parameters of the transfer function a delay map was created. The delay map 
represents the arrival time of the contrast agent at each voxel; they delay values were estimated 
by fitting the transfer function to the data and it matched the expected arrival times of the 
contrast agent. The first tests were done on DCE images of tissues with healthy vessels but since 
the main application of this model and DCE imaging is for estimating vascular physiology 
parameters for different pathologies such as brain tumors, it was necessary that in our model 
address changes in the vascular physiology due to these pathologies as well.  Even though in the 
case of most leaky vessels such as vasculature in tumors, the leakage does not disrupt the blood 
flow, however, since leaking of the contrast agent into the extravascular space changes the 
measured response of the voxels to the contrast agent, permeability parameters were 
incorporated into the model so that the function of the model matches the temporal signals from 
the images.  
Even though at this point only the morphology of healthy arteries, arterioles and capillaries have 
been included in our model, it can give a good estimate of the transfer functions of most vessels 
in the brain in its current form. Further steps in this research can involve adding abnormal 
morphologies of vessels such the vascular structure of tumors to the model and explore their 
effect on dispersion and changes in the pattern of blood flow. This can lead to more accurate 
estimation of perfusion and permeability characteristics of vessels in DCE images. Another 
application of this model and methods introduced in this dissertation is tissue characterization; 
based on the vascularity of the tissue, the CA profile can change and this can be used to classify 
it. As was noted, modeling abnormal vasculature can also be used for characterizing different 
types of tissue the DCE images based on the parameters in the model.   
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One of the most important products of our vascular model is providing a more realistic estimate 
of the contrast agent profile (TIF) the image voxels. For regions with intact vessels where there 
is no leakage of the CA agent to the extracellular space, this profile matches the tissue response 
measured by the DCE imaging very well. However, a long standing problem in DCE image 
analysis has been estimating the TIF in areas with leaky vessels. Using the EVM, we are able to 
decompose the tissue response signal into intravascular and extravascular components. This not 
only can provide an accurate estimate of the TIF, but it can also simultaneously estimate the 
permeability parameters of the leaky vessels. The estimated TIF can be used for estimating 
perfusion parameters. 
Another advantage of our method is using model averaging and model selection for choosing the 
best model to fit the data and using parameters of that model as the estimated parameters. Using 
different models to fit to the data and using model selection for finding the best fit model can 
help find the closet match to the physiologic process that had produced the data. One practical 
issue that we encountered with the Akaike model averaging method was its performance when 
dealing with noisy data. When the data is noisy, even for the best fit, the residual values cannot 
get very small and therefore when applying the logarithmic equation, the difference between the 
AIC values for various models will not differ much. Unless the difference between the residues 
is large, in these cases, when the penalty value is added (which is the number of model 
parameters), the bias will always be in favor of models with lower number of parameters.  The 
penalty value is necessary for compensating for overfitting of the models with more parameters, 
and the penalty of the Akaike method for models with more parameters is less than other 
methods such as the Bayesian method. However, by directly applying the Akaike method to our 
data, in noisy areas of the normal tissue, the lower number models are almost always favored. 
We found a solution to this problem by averaging the low intensity neighboring voxels; however, 
it would be worth to model noise and investigate the performance of the Akaike method in 
presence of it to make necessary adjustments to the method. 
In the absence of a physical phantom simulating the vascular structure and blood flow of the 
brain, we tested our model using DCE-CT and DCE-MR images of the human brain. Estimation 
of the spatial location of the vessels at different branching levels using probability maps and also 
the ability of our model to describe the profile of the CA at different levels of the vascular 
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system, with or without leakage, indicates that our model can reasonably describe blood flow, 
dispersion of the AIF and also leakage of the contrast agent to the extravascular space. Of course, 
these results are tested within the spatial and temporal resolution of our imaging.  Although a 
few research groups had made perfusion phantoms (either physically fabricated or using 
simulated data), none of them fit our specifications for our model. In most of these phantoms, the 
simulated transfer function used is an estimate of the transfer function of vessels which do not 
simulate the laminar flow and morphology of vessels of the brain as we have simulated and using 
those to validate of our model would be a fruitless effort. In the best case, the simulations will be 
using transfer functions based on laminar flow which in this case will provide us with a tool 
similar to what we have created in our simulations. An indirect method for validating our model 
is applying it to DCE images of animals for measuring permeability parameters. The advantage 
of animal models compared to human data is that the accuracy of the measured parameters can 
be evaluated using histology and autoradiography. 
The newly proposed method can have vast applications in DCE imaging and can be used for 
many classes of analysis of brain tumors, stroke or other neuro-vascular pathologies. For 
example one of the observations in the images being analyzed with this method so far has been 
that using the EVM, the tumors get classified mainly as being in the first or second levels of 
branching. This can mean that they are being directly fed by one of the main cerebral arteries 
(MCA, PCA or ACA) or their daughter vessels. A more intensive study of the CA profile in 
different grades of tumors using the model might give information on the angiogenesis involved 
with them and it can be used for tumor grading.  
As part of the future work, to expedite the fitting process for making processing time more 
practical, we will explore training an adaptive system can based on the EVM vascular model to 
be used for finding the transfer function parameters for every voxel in the image and use those 
for estimating the permeability and perfusion characteristics of the vessel. Assuming that this 
adaptive system works, it will be able process all the voxels in the brain in a matter of seconds. 
In summary, we have developed a model of the vascular system of the brain that explains 
dispersion of the CA profile in different locations of the brain vascular system and also models 
leakage of the CA to the extravascular space. We tested our model using different modalities of 
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Dynamic Contrast-Enhanced Imaging and simulated data. The results show that using this 
model, extravascular and intravascular components of the CA profile can be found in the DCE 
signal and this can be used for less biased estimates of permeability and perfusion parameters in 












In the appendix section, we will describe the methods that have used for implementing and 
testing the models. In the first section, the general methods that that are in common among all 
chapters will be described and next, the specific methodologies for each chapter will be 
explained. 
A.1 General Methods 
Modeling, visualization, simulation and programming for the GUIs and algorithms were done 
using MATLAB, version 2010b on a platform with 64-bit Windows 7 operating system. 
MATLAB toolboxes used were the Image Processing, Optimization, Parallel Computing, and 
Signal Processing Toolboxes. The Graphical User Interfaces (GUI‟s) were developed using 
GUIDE or the MATLAB (GUI development environment). 
A.1.1 The Fitting Procedure 
The main MATLAB function used for the Fitting Procedure (fminsearchbnd) was a derivation 
of the MATLAB function fminsearch. fminsearch uses the simplex search method of Lagarias 
et al. [44] which is a direct search method not based on numerical or analytical gradients and is 
categorized as a unconstrained nonlinear optimization method. This MATLAB function can find 
the minimum of a scalar function of several variables. The problem with fminsearch is that it 
does not accept any constraints on the bounds. To improve the search fitting procedure and to 
apply constraints on the variable, we used the fminsearchbnd function. This function has been 
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is a third party modified version of fminsearch and is used exactly like fminsearch, except that 
upper and lower bounds are applied to the variables.  The user defines the bounds and they are 
applied to the function internally, using a transformation of the variables. (Quadratic for single 
bound, sin(x) for dual bounds.) Since the parameters that we deal with in our method are time 
and gain, they cannot accept negative values and therefore using the constrained version of the 
search algorithm fits our applications perfectly. For the    values, the maximum value was set to 
be 2 and for the gain this value was set as   . 
The cost function used for the optimization procedure was the sum of squared errors (SSE) 
between the target curve and the curve created using the parameters found by the 
fminsearchbnd function. The SSE is defined as: 
(A.1)     ∑              
  
     
A.2 Specific Methods Used in Chapter 3 
A.2.1 Simulating the flow and vascular structure 
The starting values for simulating flow in different branches of the model were found in the 
literature as explained in section 3.2.1. These values were the length, diameter and flow in the 
major arteries of the brain and using the laws explained in chapter 3 the flow in all the sub-
branches were calculated using the simulated model.   
A.2.2 Noise added to the system in the single and two signal cases 
For simulating the TIF signals for testing the performance of our method in the two situations as 
explained in chapter 3, we have added noise to the signals and in each noise level, evaluated the 
performance of our method for first finding the level of the vascular branching for a single signal 
and secondly the ability to decompose the composite signal to its base signals. 
In the first step, to be able to compare the dispersed signals at different levels of the vascular 
tree, the simulated signals were scaled to the same power level. The scaling factor for the TIF at 
each branching level i was found as below: 
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(A.2)     
∑    
 
      
∑   
 
 
      
 
here N is the number of timepoints of the signals,    is the AIF input to the vascular structure and 
   is the simulated TIF at the i
th
 level of the vascular tree. Next, we scaled each simulated signal 
according to the scaling factor and used these signals as the base signals for the subsequent 
levels. 
To add noise to the signals, the randn command in MATLAB was used. randn(x,y) returns an x-
by-y matrix containing pseudorandom values drawn from a normal distribution with a mean of 
zero and standard deviation of 1. We used the randn command as    randn(1,n) to produce a 
vector with n elements to be added to the signal as Gaussian noise with a standard deviation of  .   
In our study, we added different levels of noise to the signals. The general definition for the 
Signal to Noise Ratio is (SNR) is as follows: 
(A.3)      
       
      
 
Where         denotes the average power of the signal and        the average power of the noise 
and were calculated as: 
(A.4)          
∑    
 
      
 
 
(A.5)          
  
Based on these equations, we applied different values to   to simulate different values of SNR. 
The noise levels that were added to the signals were 1, 4, 10, 18, 28, 37, 52, 75, 94 and 100% of 
the signal power according to the definitions above. In the second case where two signals were 
added, the noise level was calculated as a percentage of the power level of the composite signal 
based on the values above. 
In the second study where weighted sums of two signals created the composite signals, the 
contribution level of each signal was varied from 0% to 100% in increments of 10%. This 
contribution level was calculated based on the power of the signal according to the equation 
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above. After creating the composite signal, Gaussian noise was added to the composite signal 
using the same procedure as above with the same 11 levels.  
One point that should be noted is that in both of the single signal and the composite signal cases 
described above, for each level of noise, the procedure was repeated 300 times and the final 
curves that were created were the average of these signals. 
A.2.3 The Fitting Method  
Fitting was performed using the method as described in section A.1.1. In this section the function 
used and the main concepts were described. Using the MATLAB optimset command, the 
optimization options were set for the fminsearchbnd command. Using this command, the 
maximum number of iterations was set to 1,000,000 and the termination tolerance on the cost 
function value was set to     .The starting point for the    parameters in all the fitting 
procedures were set to 1 which is close to the expected value of the delay in each of the delay 
lines. The starting value for the gain factor in the fitting algorithm was selected to be    where   
is the branching level of the function that to be fitted. The cost function for the fitting procedure 
was set to the sum of squared errors (SSE) between the target TIF and the TIF created using the 
parameters found in the fitting procedure. 
A.3 Specific Methods used in Chapter 4 
The specific methods in Chapter 4 have been explained in detail in the published literature [66]. 
A.4 Specific Methods Used in Chapter 5 
In chapter 5, the extended vascular model was applied to the MR and CT signals and the Akaike 
maps were created for the two sets of images.  In this chapter there is no mention of the model 
selection and only the residual maps are shown.   
The method for estimating the transfer function is the same as that described in section A.1 with 
the difference that considering the effects of extravasation, another dimension is added to the 
fitting procedure.  The transfer function used in this chapter is described as Equation 5.8. For 
each of the six branching levels there are three possibilities of extravasation (no leakage, leakage 
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with no back-flux and leakage with back-flux) which leads to performing the fitting procedure 18 
times.  The starting values in the fitting procedure for the vascular branching parameters were set 
as in A.2.3. At each vascular level, first Model 1 was considered with the initial value of 0.01 for 
vp and fitting was performed. Next, Model 2 was considered with the vp found from fitting 
Model 1 used as the initial value and the starting point for K
trans
 set to 0.001. Finally Model 3 
was fit with the final values of vp and K
trans
 found for Model 2 to be set as the initial values for 
these parameters and the starting value of Kb was set to 0.1.  
A.5 Specific Methods Used in Chapter 6 
In this chapter, the main focus is finding the best transfer function based on the extended 
vascular model to describe the dispersion and delay of the AIF upon arrival at different levels of 
the tissue. The difference between the function described in this chapter and that in Chapter 3 is 
that effects of extravasation of the CA to the Extravascular Extracellular space has been added to 
the function. This point adds one, two or three additional parameters to the function depending 
on the extravasation model.  
Fitting was performed as described in section A.4, Using the final SSE value resulting from 
fitting each of the 18 configurations of the of models, the AIC was calculated and the model with 
the lowest AIC was selected as the best model for representing  the transfer function that 
transforms the AIF to the tissue response function in each voxel. The model selection map was 
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